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Abstract
This systematic review compared the efficacy and safety of ephedrine with phenylephrine
for the treatment of hypotension during spinal anesthesia for cesarean delivery.
Hypotension during cesarean section delivery can have detrimental effects on both the
mother and the neonate. Some vasoactive medications such as ephedrine and
phenylephrine have been found to be detrimental to the neonate and divert fetal blood
flow. After a systematic search of the electronic database PubMed, the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart was
used to identify appropriate research. Studies were illustrated in a table to identify key
variables and were then critically appraised. Outcomes included oxygen supplementation
use, ASA classification, IV fluid prehydration, hypotension incidence after spinal
anesthesia, spinal solution and technique, umbilical artery pH, Apgar scores, and nausea
and vomiting during the case. Findings revealed no difference in the use of oxygen
supplementation, ASA classification, IV fluid prehydration, spinal solution or technique
on fetal umbilical artery pH. Women given phenylephrine had neonates with higher
umbilical artery pH values than those given ephedrine but there was no significant
difference between the two vasopressors in the incidence of true fetal acidosis (umbilical
artery pH < 7.20 or Apgar <7 at 1 and 5 min). There was an incidental finding from two
studies that additionally examined nausea and vomiting that there was an increase
occurrence of nausea and vomiting with ephedrine administration as compared to
phenylephrine administration. This systematic review supports the view that ephedrine
and phenylephrine have equal efficacy and safety when administered to obstetric patients
experiencing hypotension after spinal anesthesia during cesarean sections.
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A Systematic Review Comparing Ephedrine versus Phenylephrine during Spinal
Anesthesia for Cesarean Delivery
Background/Statement of the Problem
Hypotension during spinal anesthesia for elective caesarean delivery occurs in
about 70-80% of cases (Mercier, Augè, Hoffmann, Fischer & Le Gouez, 2013) and may
have detrimental effects on both the mother and the neonate (lee, Kee & Gin 2002).
These effects include decreased uteroplacental blood flow, impaired fetal oxygenation
with asphyxial stress and fetal acidosis (Lee et al., 2002). Associated effects include
maternal symptoms of low cardiac output such as dizziness and decreased consciousness,
usually requiring vasoactive drugs as treatment (Lee et al.). Some vasoactive medications
have been found to be detrimental to the neonate and divert fetal blood flow, potentially
causing more harm than good in pregnant women (Nagelhout, Elisha & Plaus, 2013).
Ephedrine and phenylephrine are two vasoactive drugs that reportedly do not change the
blood flow to the fetus and therefore are drugs of choice in obstetric patients (Nagelhout
et al.). An important clinical question is which vasoactive drug is best for these patients?
Studies have shown that ephedrine can cause fetal acidosis as a side effect and
more so than phenylephrine; concerns about the adverse effects of phenylephrine on
uterine blood flow have also been reported (Nagelhout et al., 2013). Ephedrine is a
mixed acting adrenergic receptor agonist that has both alpha and beta agonist properties
(Nagelhout et al.). Ephedrine’s predominant beta effect causes an increase in arterial
pressure by increasing cardiac output rather than by vasoconstriction (Nagelhout et al.).
Phenylephrine is a pure alpha-adrenergic agonist which increases the blood pressure
through peripheral vasoconstriction (Nagelhout et al.). A literature review of vasoactive
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drugs conducted on animals varies in terms of the safety and efficacy of the two drugs.
The results may not apply to the human populations and may not be appropriate because
of the species differences (Lee et al., 2002).
The purpose of this paper was to conduct a systematic review to compare the
safety and efficacy of the use of ephedrine versus phenylephrine in managing maternal
hypotension during spinal anesthesia for cesarean delivery. The effect of ephedrine and
phenylephrine on uteroplacental blood flow and fetal outcome will be specifically
examined.
Next, the review of the literature will be presented.
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Literature Review
A search was conducted using PubMed. Key terms searched were cesarean
delivery, cesarean delivery complications, spinal anesthesia, hypotension, maternal
hypotension, ephedrine, phenylephrine, vasoactive medications, fetal acidosis,
uteroplacental blood flow and impaired fetal oxygenation. The time limit of the search
was from January 2001 to January 2017.
Cesarean Deliveries and Spinal Anesthesia
Cesarean sections (C-sections) are the most commonly performed operation in the
United States (US) (Gunda, Malinowski, Tegginmath, Suryanarayana & Chandra, 2010).
As reported by the Center for Disease Control and Prevention, birth by C-section
accounts for over 32% of all deliveries and is performed over 1.2 million times annually
in the US. The indications for C-sections include fetal positioning, declining fetal status,
the failure to progress, malpresentation, cephalopelvic disproportion (CPD), prematurity,
prior cesarean delivery and prior uterine surgery (Nagelhout et al.).
Regional anesthesia in C-sections offers a significant benefit over general
anesthesia. Spinal anesthesia provides a rapid onset of dense symmetrical anesthesia and
has an endpoint of cerebrospinal fluid as confirmation of placement (Suresh, Segal,
Preston, Fernando & Mason, 2012). Spinal anesthetics are relatively inexpensive and
have become the preferred anesthetic because of the superior quality of surgical
anesthesia, shorter onset time, less patient discomfort, and fewer complications than with
epidural and general anesthesia (Suresh et al.).
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Although there are several benefits to using spinal anesthesia, it is not without
complications. Hypotension is the most common side effect of spinal anesthesia because
of the profound sympathectomy produced (Suresh et al.).
Maternal Hypotension: Definition and Contributing Factors
Maternal hypotension is defined as a 20% decrease from baseline or a systolic
pressure less than 100 mmHg (Nagelhout et al., 2013). Several factors in pregnancy
physiology along with local anesthetic pharmacodynamics can contribute to the high
incidence and severity of hypotension under spinal anesthesia: the level of the block; the
concentration or density of the sensory block required for the procedure; local anesthetic
sympathetic block; the role of aortocaval compression; and a decrease in arteriolar tone
(Mercier et al., 2013).
The level of block contributes to maternal hypotension due to the vasodilating
effects of the local anesthetic combined with the anatomical position at which the block is
being administered and concentration of arteries and veins in the area (Miller & Pardo,
2011). The greater the concentration of the block or denisty of the block, along with the
greater presence of arteries and/or veins in the anatomical area, the more likely to result
in an increased sympathectomy and therefore hypotension (Miller & Pardo). Local
anesthetics also cause a sympathetic block and therefore result in parasympathetic
override which can result in hypotension due to a decrease in venous return to the heart, a
decrease in cardiac output and a decrease in systemic vascular resistance (Miller &
Pardo). Local anesthetics vasodilator effect largely impacts arteries, resulting in a
decrease in arteriolar tone which can contribute to the incidence and severity of
hypotension in spinal anesthesia (Miller & Pardo). This decrease in arteriolar tone is the
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main mechanism and supports why vasopressors are the most important option in the
management of hypotension (Mercier et al., 2013).
Aortocaval compression, defined as compression of the vena cava when lying in
the supine position due to the gravid uterus, causes a decrease in venous return to the
heart and therefore hypotension. This can significantly contribute to the hypotension
already caused by local anesthetics vasodilation (Nagelhout, et al., 2013). Aortocaval
compression is a major contributor to hypotension in pregnant women based on female
physiology and is a syndrome of supine hypotension in term or near-term pregnant
women (Nagelhout et al.). The compression of the vena cava can worsen when the
abdomen is tense or when the uterus is larger than normal. This decrease in venous
return results in a significant reduction in stroke volume and decreases cardiac output.
Nagelhout et al. elaborated that the normal physiological response to aortocaval
compression is tachycardia and vasoconstriction of the lower extremities. Despite this
compensation, uterine blood flow and therefore fetal oxygenation is reduced.
Compression of the aorta and vena cava is usually relieved by shifting the uterus to the
left. Prevention of aortocaval compression is universally recommended to prevent
hypotension and avoid the risk of abrupt fall in venous return and thus decreased cardiac
output and blood pressure (Mercier et al., 2013). During patient placement for cesarean
delivery, a wedge placed under the right hip or operating room table tilted left is used to
relieve aorta or vena cava compression (Mercier et al.).
Maternal Hypotension and Fetal Acidosis with Spinal Anesthesia
Prolonged maternal hypotension may result in uteroplacental hypo-perfusion and
therefore fetal acidosis (Gunda et al., 2010). Fetal hypoxia can occur when maternal
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perfusion of the placenta is reduced or delivery of oxygenated blood from the placenta to
the fetus is impeded (Omo-Aghoja, 2014). When fetal hypoxia is present, metabolism
proceeds via an anaerobic pathway and therefore lactic acid is produced, which can
accumulate and result in metabolic acidosis (Omo-Aghoja). Umbilical cord blood
sampling is performed to examine blood from the fetal umbilical cord to detect fetal
abnormalities (Huch, Huch & Rooth, 1994). Blood from the umbilical vein reflects the
placental function whereas blood from the umbilical arteries reflects blood coming from
the fetus (Huch et al.). Hypo-perfusion on the maternal side can cause a decrease in
partial pressure of oxygen (PO2) in the umbilical vein; a low umbilical artery oxygen
level (PaO2) indicates a risk of fetal tissue hypoxia (Huch et al.). Umbilical cord blood
sampling is indicated when umbilical cord blood gas levels and percent of hydrogen (pH)
are needed to aid in the diagnosis of certain conditions such as fetal acidosis (Huch et al.).
Fetal acidosis is defined as a pH less than 7.16, with adverse neonatal outcomes occurring
with a pH less than 7.0 (Omo-Aghoja, 2014).
The Apgar score provides an accepted and convenient method for reporting the
status of the newborn infant immediately after birth (American Academy of Pediatrics,
2015). The Apgar score is comprised of five components including color, heart rate,
reflexes, muscle tone, and respirations. Each element is given a score of 0, 1, or 2. The
score is reported at one minute and five minutes after birth for all infants and at five minute intervals after that for infants with a score less than 7, up to 20 minutes (American
Academy of Pediatrics). The Apgar score quantifies clinical signs of neonatal depression
with free signs of cyanosis, pallor, bradycardia, depressed reflex response to stimulation,
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hypotonia and apnea or gasping respirations. All of these symptoms may be present when
a neonate experiences fetal acidosis (American Academy of Pediatrics).
Treatment of Maternal Hypotension
Vasopressors are the most important option in the management of hypotension
(Mercier et al., 2013). Ephedrine and phenylephrine are two vasoactive drugs that have
been reported to not change the blood flow to the fetus and therefore are drugs of choice
in obstetric patients (Nagelhout et al., 2013). Until recently, ephedrine was the more
favored agent in treating maternal hypotension but several studies have shown that
ephedrine risk may outweigh its benefits. As a result, there has been an increase in
practitioners’ use of phenylephrine to treat maternal hypotension (Mercier et al., 2013).
Each drug will be briefly reviewed next.
Ephedrine: Pharmacokinetics and Indications for Treatment of Maternal
Hypotension. Ephedrine is a mixed acting adrenergic receptor agonist that has both alpha
and beta agonist properties (Nagelhout et al., 2013). The adopted use of ephedrine was
initially supported by a study conducted by Ralston and Shnider (1974) that examined
sheep to determine uterine blood flow with different vasopressors. Results showed that
ephedrine preserved uterine blood flow, while drugs with increasing alpha agonist
properties produced potent vasoconstriction of the uterine vascular bed. A landmark
study performed by Kang in 1982 showed that a continuous infusion of ephedrine was
extremely effective at preventing maternal hypotension during elective caesarean
delivery versus a control group that received ephedrine only when hypotension occurred.
Ralston and Shnider’s study results were reinforced when McGrath et al. (1994)
performed a similar study with a randomized design. These authors confirmed that unlike
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phenylephrine, ephedrine improved uterine blood flow without increasing uterine
vascular resistance when given after epidural anesthesia-induced hypotension. Later
studies, which will be reported in the next section, compared the use of ephedrine and
phenylephrine.
Phenylephrine: Pharmacokinetics and Indications for Treatment of
Maternal Hypotension. Phenylephrine is a pure alpha-adrenergic agonist that increases
the blood pressure through peripheral vasoconstriction (Nagelhout et al.). In the 1990s,
phenylephrine began to be used more cautiously in clinical practice as a rescue
vasopressor to control maternal hypotension, tachycardia and other symptoms when
ephedrine had failed (Taylor & Tunstall, 1991). Subsequently, direct comparison of
ephedrine and phenylephrine began to challenge the standard use of ephedrine by
reporting that the pure alpha agonist produced a better umbilical artery pH (Morgan,
1994). In 2002, Lee et al. performed a meta-analysis of six trials (n=200) comparing
ephedrine and phenylephrine used to treat maternal hypotension with spinal anesthesia
for cesarean delivery. Results suggested that phenylephrine resulted in better umbilical
arterial pH than ephedrine but no difference in the incidence of true fetal acidosis or
Apgar score below 7 at 1 minute (RR of 0.77; 95% CI, 0.17-3.51) and five minutes (RR
of 1.00; 95% CI, 0.21-4.83) after birth. Pooling the results showed that women given
phenylephrine had neonates with higher umbilical arterial pH values than those given
ephedrine (WMD = 0.03; 95% CI, 0.02-0.04, mean ephedrine umbilical arterial pH
values ranging from 7.27-7.29). Also, women given phenylephrine had neonates with
greater venous pH values than those given ephedrine (WMD = 0.02; 95% CI, 0.01-0.03,
mean ephedrine venous pH values ranging from 7.29-7.35). The risk of true fetal
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acidosis, which was defined as a pH value of <7.20, was similar between the
phenylephrine and ephedrine groups (RR of 0.78; 95% CI, 0.16-3.92) (Lee et al.).
Phenylephrine has been demonstrated to be detrimental to the well-being of the
fetus, based on numerous animal models (Mercier et al., 2013). When ephedrine began
to be reported to cross the placental barrier easily and cause a decrease in umbilical
arterial pH or ephedrine failed to treat the maternal hypotension, phenylephrine began to
be used cautiously (Mercier et al.). While phenylephrine effectively prevents hypotension
and provides a proper neonatal pH, it can cause bradycardia (Mercier et al.). The
mechanism is thought to be due to a baroreceptor-mediated response in cardiac afterload
due to increased systemic vascular resistance. The response may also be due to cardiac
sympathetic denervation associated with spinal blocks which could be masked when
ephedrine is used because of its beta-adrenergic chronotropic effect (Mercier et al.). This
bradycardia may result in a decrease in cardiac output which can further harm the fetus
(Mercier et al.). Further analysis of ephedrine and phenylephrine specific to impact on
maternal hypotension and fetal outcomes is indicated.
Next, the frameworks used to guide this review will be presented.
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Theoretical Frameworks
Systematic reviews and meta-analyses are a vital component of evidence-based
healthcare and as such they support the development of clinical practice guidelines and
inform clinical decision-making (Moher et al., 2015). The Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) is used to accurately report highquality systematic reviews as well as meta-analyses. PRISMA was created in 2009 after
the previously used Quality of Reporting of Meta-Analysis (QUOROM) statement (1999)
was revised (Atlman et al., 2009). The new PRISMA statement allows for standardization
and improvement of the quality of the systematic reviews being produced (Atlman et al.).
Although the PRISMA update in 2009 was thought to correct many missing pieces and to
promote consistency to systematic review research, there remained the issue of how to
include studies with greater than two interventions. To address this issue, experts in
research added five more items to the checklist, in the methodology section (Moher et al.,
2015). Since this author will only be examining two primary variables, ephedrine and
phenylephrine, the 2009 PRISMA checklist, as well as the 2009 flow diagram, will be
used. The flowchart was modified to include the number of articles identified, those
included as well as those excluded (Moher et al., 2009). The 27-item checklist was
created with items thought to be necessary for transparency of data (Moher et al.). The
items on the checklist give researchers a step-by-step guide while allowing them to
present their research in an accurate and succinct manner (Moher et al.).
The PRISMA statement consists of a 27 item checklist (Table 1) which lays out
the requirements for evidence-based studies (Moher et al., 2009). Table 1 can be viewed
on the next page. Items on the checklist include seven major sections including title,
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abstract, introduction, methods, results, discussion, and funding. Within each heading are
subheadings as well as descriptions defining the expectations for each of the sections.
The PRISMA checklist will be used to ensure that all items required to complete a
systematic review are presented in the completion of the research.
Table 1
PRISMA Checklist
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Along with the checklist is the PRISMA four-phase flow diagram (Figure 1) that
helps to dictate the literature search procedure (Moher et al.,). The flow chart illustrated
below elucidates the screening and evaluation for eligibility within the research.

Figure 1. PRISMA Flow Diagram. This figure illustrates the PRISMA statements flow
diagram used for the search strategy performed when conducting a systematic review and
to evaluate the eligibility of studies.
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
flowchart supports the attainment of appropriate research. This flowchart also provides a
step-by-step set of instructions for articles included for analysis. The flow diagram
outlines the records excluded from the study and ask for reasons why to be reported
(Moher et al., 2009). It begins with the identification of articles through database
searching, the screening of such items for appropriateness and eligibility, and ends with
the final articles to be included within the research; the process can be reviewed in Figure
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1 (Moher et al., 2009). PRISMA may also be useful for critical appraisal of published
systematic reviews but is not a quality assessment instrument (Moher et al.)
The Critical Appraisal for Summaries of Evidence (CASE) worksheet (Table 2) is
used to assess the quality of evidence (Foster & Shurtz, 2013) and will be used to
critically appraise the studies.
Table 2
CASE Worksheet
Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation

Summary Topic
1. Is the summary specific in scope and
Yesapplication?
Not completelyNoSummary Methods

2. Is the authorship of the summary
transparent?
3.

4.

5.

6.

7.

8.

9.

10.

YesNot completelyNoAre the reviewer(s)/editor(s) of the
Yessummary transparent?
Not completelyNoAre the research methods transparent
Yesand comprehensive?
Not completelyNoIs the evidence grading system
Yestransparent and translatable?
Not completelyNoSummary Content
Are the recommendations clear?
YesNot completelyNoAre the recommendations appropriately
Yescited?
Not completelyNoAre the recommendations current?
YesNot completelyNoIs the summary unbiased?
YesNot completelyNoSummary Application
Can this summary be applied to your
Yespatient(s)?
Not completelyNo-

The CASE worksheet is comprised of 10 questions examining specificity,
authorship, reviewers, methods, grading, clarity, citations, currency, bias, and relevancy
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of each study (Foster & Shurtz, 2013). The researcher must answer these questions as
either “yes”, “no”, or “not completely”. Traditionally, the CASE worksheet is utilized to
assess the quality of point-of-care tools and treatment modalities that directly effect
patient outcomes. The quality assessment data within the studies will be determined
through the application of the CASE Worksheet. Each study will be appraised through
answering the ten CASE worksheet questions and then all the studies will be compared
based on the results and listed from highest to lowest quality, one being the highest
quality and five being the lowest quality based on the CASE worksheet results.
Cross study analysis was conducted using a process called descriptive data
synthesis, which can be accomplished by both a narrative and a tabulation approach
(Evans, 2002). This process will be further described in the methods section.
Next, the methods used to conduct this systematic review will be discussed.
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Method
Purpose of Study/Clinical Question
The purpose of this systematic review was to compare the safety and efficacy of
the use of ephedrine versus phenylephrine in managing maternal hypotension during
spinal anesthesia for cesarean delivery. The effects of ephedrine and phenylephrine on
uteroplacental blood flow and fetal outcome was specifically examined.
The question posed was: Is either ephedrine or phenylephrine more effective and
safer when used to treat hypotension during spinal anesthesia for cesarean delivery?
Outcomes Examined
The specific outcomes assessed included maternal blood pressure, maternal heart
rate, fetal acidosis as measured by neonatal umbilical cord blood arterial and/or venous
pH and Apgar score.
Inclusion and exclusion criteria
Inclusion criteria encompassed: studies specific to cesarean delivery with spinal
anesthesia that examined: maternal hypotension; ephedrine and phenylephrine; fetal
acidosis with or without Apgar scores. Only randomized control trials or systematic
reviews published from January 2001 to January 2017 were included. Exclusion included
any studies before January 2001 and those not meeting all of the inclusion criteria.
Search Strategy
Applying both the PRISMA flowchart as well as the PRISMA checklist, research
articles were obtained from the database PubMed. The search was conducted using the
terms cesarean delivery, cesarean delivery complications, spinal anesthesia, hypotension,
maternal hypotension, Ephedrine, Phenylephrine, vasoactive medications, fetal acidosis,
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uteroplacental blood flow and impaired fetal oxygenation. The results of the search were
applied to the PRISMA flow diagram (Figure 1) to support selection for inclusion in the
systematic review.
After removing any duplicates located, the investigator then assessed the
remainder of the studies for inclusion criteria. Eligibility assessment was performed
independently in an unblinded and unbiased standardized manner by the student
researcher. Initial steps involved first reviewing both title and abstract for eligibility. The
remaining studies were then further screened for eligibility through examination of the
entire study and the reasons for exclusion of those that did not qualify was noted. The
number of articles being used for data synthesis were identified (PRISMA, 2009).
Data Collection for Each Study
Table 3 served as a data collection table to organize pertinent data from each
study. This table was used to organize and summarize information gathered from the
research articles included in the study and ensured that all required criteria as stated by
PRISMA were captured.

Table 3
Data Collection Tool
Method/Level
of evidence &
Data
Major
Sample/setting Intervention
Analysis
Variables
Studied

Results

limitations
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Critical Appraisal Tool
The purpose of a critical appraisal is to determine how credible the study is in
practice (Fineout-Overholt, Melnky, Stillwell & Williamson, 2010). The quality
assessment data within the studies was determined through the application of the CASE
Worksheet (Table 2) illustrated earlier in the framework section. All 10 questions
examining specificity, authorship, reviewers, methods, grading, clarity, citations,
currency, bias, and relevancy of each study were answered. The hierarchy of evidence for
assessing healthcare research will also be used to determine the level of evidence of each
study (Melnyk & Fineout-Overholt, 2011).
Descriptive data synthesis
Descriptive data synthesis can be attained by both means of a narrative and also a
tabulation approach to describe the literature (Evans, 2002). Evans (2002) stated that
using both narrative and tabulation data synthesis allows a more comprehensive view of
the literature by decreasing limitations than if just one method was used. A narrative was
completed to summarize the studies individually as well as across each study in order to
identify themes and patterns. The outcome of safety and efficacy of the use of ephedrine
versus phenylephrine was examined and further tabulated into more detail in Table 4,
illustrated on the next page and then examined for comparisons across the studies.
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Table 4
Descriptive Data Synthesis Tool

Study

Oxygen
supplementation
Used

Intravenous
Fluid
Prehydration

ASA
Classification/patient
characteristics

Hypotension
incidence after
spinal anesthesia

Spinal
Solution and
Technique

Umbilical
artery pH

Apgar
scores

N/V
during
case

Other
important
findings

Through the descriptive data synthesis and comparison across the studies, the
following questions were addressed:
•

Which medication causes less umbilical cord arterial and/or venous blood
acidosis: phenylephrine or ephedrine?

•

Which medication causes the least decrease in infant Apgar scores: phenylephrine
or ephedrine?

•

Was oxygen administered to the mother during c-section and could this be
correlated with fetal acidosis?

•

Was the mother administered IV pre-hydration prior to the spinal that could effect
the incidence of hypotension seen?

•

What were the characteristics of the patient studied?

•

Was there a correlation between hypotension after spinal anesthesia and the spinal
anesthesia medication used?

•

Were there any incidental findings that can be contributed to fetal acidosis?

Next, study results will be presented.
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Results
The PRISMA flowchart (Figure 2), illustrated below, along with the inclusion and
exclusion criteria aforementioned, were used to further eliminate and select articles for
the systematic review. After the database search, a total of 44 non-duplicate citations
were screened. The abstracts of these articles were reviewed for evidence of exclusion
criteria that would deem them not appropriate for the systematic review. This process
eliminated a total of 22 articles. The remaining 22 articles were reviewed in their entirety
for relevance and selected for the systematic review based on both exclusion and
inclusion criteria. The final elimination process omitted 16 articles, leaving a total of six
articles for inclusion within the final systematic review.
PubMed January 2001January 2017
44 Citation(s)

44 Non-Duplicate
Citations Screened

Inclusion/Exclusion criteria
applied

22 Excluded After title/abstract
screened

22 Articles Retrieved

Inclusion/Exclusion criteria
applied

16 Excluded After Full text screened

6 Articles Included

Figure 2. Search Strategy Using PRISMA Flow Diagram. This figure illustrates the
search strategy performed and applies the results found to the PRISMA flow diagram.
Of the six articles that remained, five were randomized control trials and one was
a retrospective observational and chart review study. The following section summarizes
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each individual study as derived from the data collection tool (Appendix A) after the
summary of each study, a critical analysis of the study is provided (Appendix B). The
retrospective chart review will be reviewed first, followed by the RCTs which will be
presented chronologically.
The retrospective observational study and chart review conducted by Cooper et al.
(2010) (Appendix A-1) included 385 women with high risk pregnancies that had a
cesarean section under spinal anesthesia for singleton delivery where fetal umbilical
artery and venous pH were recorded. Charts were reviewed within a four-year period
from 2000-2003. Once women for the study were identified, the authors then reviewed
the notes, recording maternal and fetal demographic and operative data. Blood gas
values, taken from a double clamped segment of umbilical cord at delivery and five
minute Apgar scores assessed by a midwife upon admission to the neonatal unit were all
recorded. During the study, ephedrine was routinely given as 6mg boluses and
phenylephrine as 100 mcg boluses, at the discretion of the anesthetist. Phenylephrine was
started at 33 mcg/min immediately following spinal injection and then titrated, aiming to
keep systolic blood pressure (SBP) at baseline. The infusion rate was doubled or halved
as required. The maximum infusion rate was 67 mcg/min. If there was hypotension
despite the prophylactic infusion, 100 mcg boluses of phenylephrine were given. There
were no guidelines for ephedrine infusion.
One hundred and twelve participants per group would give the study an 80%
chance of detecting a 0.03 difference in umbilical artery pH, at P=0.05, based on a
standard deviation of 0.08 for umbilical artery pH for non-elective C-section under spinal
anesthesia. Secondary outcomes were the incidence of fetal acidosis (pH <7.20), low 5
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minute Apgar score (<7) and admission to the neonatal unit. Mann-Whitney and KruskalWallis tests were used for direct comparison of the groups and subgroups. Forward
stepwise multiple regression analysis was used to find which independent variables were
associated with umbilical artery pH. Results revealed that there was no difference in
umbilical artery pH between the three groups on direct comparison (P=0.21). Following
forward stepwise multiple regression analysis, the only variable that was associated with
altered pH was non-reassuring fetal heart rate trace (P=0.71).
Critical analysis of the Cooper et al. (2010) study using the CASE worksheet
(Appendix B-1) found that the study met six out of 10 criterions. The authors clearly
identified the aim of the study as well as the patients that the study applied to. Although
the individual authors were identified with their affiliations, their credentialing was not
listed. Whether the study was edited or reviewed was also not clearly stated. The
inclusion and exclusion criteria and protocol for the study were clearly stated. The study
was a retrospective observational chart review study therefore level IV evidence based on
the hierarchy of evidence (Melnyk & Fineout-Overholt, 2011). The protocol used in
reviewing the charts was clearly stated. Although recommendations for practice were not
current, they were clearly stated and multiple options for treatment were provided and
could be applied to any setting and population. It was unable to be determined if there
was a conflict of interest.
Cooper et al. (2002) (Appendix A-2) conducted a randomized/double blind study
including 147 ASA I and II women scheduled for elective C-section of a singleton
pregnancy under spinal anesthesia with no other comorbidities. Before entering the
operating room, vital signs were taken three times and the lowest of the three was
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considered the baseline. Baseline nausea and vomiting scores were also assessed. The
participants, anesthetists, nurses and midwives involved were all blinded to the patient
grouping. There were three groups: The P group received phenylephrine 100mcg/ml; the
E group received ephedrine 3mg/ml; and the C group received a combination of
phenylephrine 50mcg/ml combined with ephedrine 1.5mg/ml. One of four spinal
anesthetics techniques was used based on provider preference. Immediately before spinal
anesthesia, a preload of 10ml/kg of Hartmann solution was rapidly infused. Immediately
following spinal injection, the infusion of IV vasopressor solution was started according
to protocol. The patient was then positioned supine with a left lateral tilt. Systolic arterial
pressure and heart rate were measured every minute. The rate of the solution was doubled
or halved if the systolic arterial blood pressure (BP) fell below or above 0.75 times the
baseline. Phenylephrine was started at 33mcg/min; ephedrine was started at 1mg/min or
half the dose rate for each for the combination solution. The maximum nausea and
vomiting score was recorded between spinal and delivery. At delivery, one of the
investigators obtained umbilical artery and vein blood samples from a segment of the
umbilical cord double clamped before the babies’ first breath. No supplemental O2 was
given to the mother prior to delivery. The APGAR scores were recorded at one and five
minutes by a midwife. The Kruskal-Wallis test was used to compare the three groups. If a
difference was found with the Kruskal-Wallis test, pairs of groups were then compared
using the Mann-Whitney U test. The Wilcoxon signed-rank test and spearman rank test
were also used to analyze data. The Wilcoxon signed-rank test was used to compare data
within a group.
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All participants were comparable for age, height, weight, gestation, breech
presentation, previous c-section, delivery and birth weight. Forty-eight participants in the
phenylephrine group (P group), 50 in the ephedrine group (E Group) and 49 in
combination of phenylephrine and ephedrine solution group (C group) were studied. Fetal
acidosis was less frequent in the P group (1 of 48) and less frequent in the C group (1 of
47) than in the E group (10 of 48), (overall P=0.0007). There was no difference in the
incidence of fetal acidosis between the P and C groups (P=0.99). One and five min
APGAR scores were normal in all three groups. Blood gas values were similar for the P
and C groups; the E group had a lower umbilical artery pH than the P group (P=0.002) or
the C group (P=0.009) and a lower umbilical vein pH than the P group (P=0.04) or the C
group (P=0.003). There was no difference in the umbilical vein PCO2 between the
groups but the E group had a higher umbilical artery PCO2 than the P group (P=0.002).
There was no change in the P group from baseline N/V scores (P=0.30) but in the E and
C group the N/V scores increased from baseline (E= P<0.0001) (C = P=0.007). The N/V
scores were lower in the P group than in the E group (P<0.0001) or C group (P<0.0001)
but there was no significant difference between the E and C groups (P=0.09). In the E
group, vomiting (n=18) was associated with decreased HR and SABP and increased
ephedrine doses. The incidence of fetal acidosis and vomiting at cesarean delivery under
spinal anesthesia was reduced by giving phenylephrine alone or in combination with
ephedrine versus giving ephedrine alone.
The CASE worksheet was then applied to the study by Cooper et al. (2002)
(Appendix B-2). The study was found to meet seven out of ten criteria. The aim of the
study was clearly stated as well as the patients that the summary applied to. The
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individual authors were listed along with their credentialing and affiliations. It was not
clearly stated that the study had been edited and reviewed. The inclusion and exclusion
criteria were clearly stated as well as the protocol followed for the study. This study was
a randomized double-blinded study which is level II evidence (Melnyk & FineoutOverholt, 2011). The study stated that randomization was performed by randomly
allocating patients by envelope selection to one of three groups and that all participants
and investigators were blinded to the group and that unlabeled syringes were used. A
third party not involved in the study opened the envelope and handed the appropriate
medication to the investigator. The recommendations were clearly stated and multiple
options for treatment were provided. The recommendations were from 2002 and therefore
not current. It was unable to determine if there was a conflict of interest between the
recommendation of the summary and the sponsor for any author. The evidence and
setting for this study applies to many populations and settings.
Ngan Kee et al. (2008) (Appendix A-3) performed a randomized double blind
study of 204 ASA I and II women with singleton pregnancies scheduled for non-elective
C-section for which spinal anesthesia was decided upon for clinical reasons at any point
in time. Standard monitoring was applied. No IV prehydration was given. Spinal
anesthesia was induced with the patient in the right lateral position at L3-4 or L4-5 with
2.0-2.2 ml of hyperbaric 0.5% bupivacaine (10-20 mg) and fentanyl 15 mcg. The patients
were then immediately turned to supine with a left lateral tilt and a rapid IV co-hydration
with up to 2 liters of lactated ringer’s solution was administered and oxygen of 6-8 L/min
delivered by clear facemask until delivery. Participants were randomized to receive an IV
bolus of either phenylephrine 100 mcg (group P) or ephedrine 10 mg (group E)
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immediately after each episode of hypotension. Umbilical arterial (UA) and umbilical
venous (UV) blood samples from double-clamped segments of umbilical cord were
obtained. The attending pediatrician assessed APGAR scores at one and five minutes
after delivery. Univariate intergroup comparisons were made using the unpaired student’s
t-test or the Mann-Whitney U-test as appropriate. Nominal data were compared using the
Chi-Square test or Fisher’s exact test.
The number of doses of vasopressor required was similar between groups. More
participants had nausea or vomiting in the E group than the P group (13/102 (12.7%) vs
4/102 (3.9%), P=0.02). There was no difference between groups in the primary outcome,
UA pH. In the E group, two cases had a UA pH <7.0 compared with no cases in the P
group (P=0.50). The UA PO2 was lower in the P group vs the E group (median
difference 0.23 [95% CI of difference 0.20-0.45]; P=0.032) and UV PO2 was lower in the
P group vs the E group (Median difference 0.39 [95% CI of difference 0.08-0.70;
P=0.012). However, there was no difference between groups in UA or UV oxygen
content. There was no difference between groups in the clinical outcome of the neonates.
Both phenylephrine and ephedrine are suitable vasopressors for use in non-elective Csections.
The study by Ngan Kee et al. (2008) was then critically appraised using the CASE
worksheet (Appendix B-3). The study met six out of 10 criterions. The aim of the study
was clearly stated as well as the patients that the study applied to. Although the individual
authors and their affiliations were listed in the study, their credentialing was not. It was
not clearly stated that the study was edited or reviewed. The inclusion and exclusion
criteria were clearly stated as well as the protocol for the study. The study is level II
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evidence being that it is a randomized double-blinded study (Melnyk & FineoutOverholt, 2011). The study stated that randomization was performed using computer
generated codes contained in opaque, sealed and sequentially numbered envelopes as
well as medications prepared in identical syringes by someone not involved in the study.
Recommendations were clearly stated and multiple options for treatment were provided.
The recommendations are not current as the study was completed in 2008. It was unable
to determine if there was a conflict of interest between the recommendation of the
summary and the sponsor for any author. The evidence and setting for this study applies
to many populations and settings.
A randomized double blind study by Prakash et al. (2010) (Appendix A-4) studied
60 ASA I women with singleton pregnancies scheduled for elective caesarean delivery
under spinal anesthesia. Standard monitoring was applied. Each patient also received a
10ml/kg IV infusion of Lactated Ringers solution over 15-20 min before spinal
anesthesia. With participants in the left lateral position, 2ml 0.5% Hyperbaric
Bupivacaine was injected intrathecally at L3-4. Oxygen 6L/min via face mask was given
until delivery. Participants were divided into two groups: P group (phenylephrine) and E
group (ephedrine). Group E received 1ml bolus of ephedrine 6mg/ml; group P received a
1 ml bolus of phenylephrine 100 mcg/ml. Additional boluses were administered if the
systolic pressure remained at or below 80% of baseline. The incidence of nausea and
vomiting, arterial and venous blood samples from a double clamped segment of the
umbilical cord and Apgar scores at one, five and ten minutes were determined by the
attending pediatrician and all were recorded. Descriptive statistics were calculated for
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continuous variables as mean and standard deviation and for categorical variables as
frequency of distribution and percentage.
The two groups were comparable in age, weight, height, baseline hemodynamic
data and dermatomal sensory levels. Apgar scores at one, five and ten minutes were
comparable in the two groups with no neonate having an Apgar score < 7 at any time. No
umbilical artery pH was less than 7.20. Umbilical artery and venous pH were
significantly lower in group E than in group P (p=0.01 and P=0.002). Results showed that
100 mcg bolus doses of phenylephrine were as effective as 6 mg bolus doses of ephedrine
in the treatment of hypotension following spinal anesthesia in term parturients
undergoing c-section delivery. Neonates of women treated with phenylephrine had
higher umbilical cord pH though true fetal acidosis was not seen in any neonate.
The study by Prakash et al. (2010) was also critically appraised using the CASE
worksheet (Appendix B-4). The aim of the study was clearly stated as well as the patients
that the study applies to were well described. The individual authors and their affiliations
were listed but credentialing was not. It was not clearly stated if the study was edited or
reviewed. The inclusion and exclusion criteria were clearly stated as well as the study
protocol that was followed. This study was a randomized double-blinded study making it
level II evidence (Melnyk & Fineout-Overholt, 2011). The randomization was performed
by computer generated number allocation and identical syringes prepared by someone not
involved with data collection were utilized. Recommendations for practice were clearly
stated and multiple options for treatment were provided. The recommendations are from
2009 and therefore not current. It was unable to determine if there is a conflict of interest
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between the recommendation of the summary and the sponsor for any author. The
evidence and setting for this study applies to many populations and settings.
A randomized double blind study completed by Mercier et al. (2013) (Appendix
A-5) included 42 ASA I and II women with singleton pregnancies scheduled for
caesarean section delivery under spinal anesthesia. Standard monitors and oxygen via
nasal cannula were applied. Baseline vitals signs were obtained. Intravenous preload of
15ml/kg Lactated Ringer’s solution was given prior to spinal anesthesia of 11mg of
hyperbaric 0.5% Bupivacaine, 2.5 mcg Sufentanil and 0.1 mg morphine at L2/3 or L3/4.
A prophylactic vasopressor IV infusion was started at the end of spinal injection.
Participants received either 2mg/min ephedrine plus 10 mcg/min phenylephrine (E+P
group) or 2mg/min ephedrine alone (E group). Infusions were halved, stopped or doubled
based on study protocol. Groups were compared for single parametric, ordinal and
nominal variables using unpaired student t test, the Mann-Whitney U test, and Fisher
exact test, respectively. Hemodynamic values over time were compared using analysis of
variance for repeated measures, followed by Dunnett tests.
Participants were all comparable for demographic characteristics, gestational age,
neonatal weight, upper sensory level of anesthesia, time from spinal anesthesia to
incision, time from spinal anesthesia to delivery and from uterine incision to delivery,
baseline SBP and maternal HR. Umbilical venous and arterial pH values were
significantly higher in the E+P group. The incidence of arterial pH <7.20 was 31% higher
in the E+P group and 63% in the E group (P=0.09). However, Apgar scores at one and
five minutes were similar in both groups and were never less than 7. Low venous and
arterial pH values were associated only with the E group assignment and spinal
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anesthesia to delivery times longer than 33 min. Compared with ephedrine alone,
ephedrine plus phenylephrine infusions decreased the incidence of hypotension by
approximately 50%, abolished maternal tachycardia and improved venous and arterial
pH.
The CASE worksheet was applied to the study by Mercier et al. (2013) (Appendix
B-5). The study met seven out of 10 criterion of the CASE worksheet. The aim of the
study was clearly stated and the patients that the aim applied to were well described. The
individual authors were listed along with their credentialing and affiliations. The
inclusion and exclusion criteria were clearly stated and a protocol for the study was stated
and followed. This study was a randomized double-blinded study therefore making it
level II evidence (Melnyk & Fineout-Overholt, 2011). The study stated that
randomization was performed by using numbered, sealed, opaque envelopes ensuring
both the patient and investigators were blinded to group assignment and study solutions
were prepared by those not involved in the patient’s care and according to the group
indicated by the envelope. There was an investigator present during the study period to
confirm comparability and routine procedures. The recommendations for practice were
clearly stated and multiple options for treatment were provided even though the evidence
was not considered current. It was unable to determine if there was a conflict of interest
between the recommendation of the summary and the sponsor for any author. The
evidence and setting for this study applies to many populations and settings.
Moslemi & Rasooli (2015) (Appendix A-6) performed a randomized double blind
study which included 83 healthy pregnant women with gestational age of 36 weeks or
greater for elective cesarean section under spinal anesthesia. Participants were assigned to
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three different groups: phenylephrine (group Ph), ephedrine (group E) and placebo (group
P). Standard monitoring was applied. Prior to spinal anesthesia, all participants received a
500 ml crystalloid bolus. Infusion of study drugs were: group Ph received 450 mcg of
phenylephrine in 250 ml; group E received 45 mg of ephedrine in 250 ml; and group P
received an infusion of only 250 ml normal saline. The participants then received spinal
anesthesia in the sitting position at L4/5 or L3/4 with 2.5 ml of Bupivacaine 0.5%
(12.5mg) and 2.5 mcg of Sufentanil. After delivery and clamping of the umbilical cord,
1ml of blood was drawn from the umbilical artery for neonatal blood gas analysis. One
minute and five minute APGAR scores were recorded as well as the umbilical artery
blood gas analysis. Any decrease in BP of about 20% from baseline was treated with 50100 mcg phenylephrine in pH group or 5-10 mg ephedrine in E and P groups. Data were
analyzed using a one-way ANOVA for quantitative variables and Fishers exact
probability tests and chi-square for qualitative variables and associations. Multiple
comparisons were tested by post-hoc with Turkey technique. Normal distributions of data
were evaluated by Kolmogorov-Smirnov normality test.
There was no significant difference in demographic data. Indications for c-section
included repeated c-section (n=53), other indications (n=25) and patient preference (n=4).
Additional doses required for the treatment of hypotension was higher in groups E
(65.2%, n=15) and P (80%, n=20) than in group Ph (28.57%, n=10). There was a
significant difference in the 5 min APGAR scores which was better with group Ph and E
rather than group P (P=0.002). Umbilical artery (UA) blood gas analysis showed a
significant difference in pH and PCO2 between Ph and P groups. Two neonates in the Ph
group, seven in the E group and five in the P group had acidosis. Acidosis was
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significantly lower in phenylephrine group (P=0.043). Overall results showed that for
women who underwent spinal anesthesia for elective c-section, SBPs and neonatal UA
pH were best maintained with a prophylactic infusion of phenylephrine compared with
those who did not receive it and were even better than those who received prophylactic
ephedrine.
Finally, the study by Moslemi & Rasooli (2015) was critically appraised using the
CASE worksheet (appendix B-6). The study met eight out of 10 criterion. The aim of the
study was clearly stated and the patients that the study applied to were well described.
The individual authors were listed along with their credentialing and affiliation. It was
not clearly stated if the study was edited or reviewed. The inclusion and exclusion criteria
were clearly stated as well as the protocol used. This study was a randomized clinical trial
making it level II evidence (Melnyk & Fineout-Overholt, 2011). The study stated that
randomization was performed using a table of random numbers and computer generated
randomization list. Recommendations for practice were clearly stated and multiple
options for treatment were provided; the recommendations were from 2015 making them
current. It was unable to appropriately assess if there was a conflict of interest between
the recommendation of the summary and the sponsor for any author. The evidence and
setting for this study applies to many populations and settings.
Cross Study Analysis
All but one of the studies included in this systematic review were randomized
control trials; the Cooper et al. (2010) study was a retrospective chart review study.
Descriptive data synthesis of the included studies are illustrated in Appendix C. Key
variables were identified and analyzed across the six studies. All six studies had different
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intervention groups; some included a combination of medications and some contained a
placebo group. The sample size for all six studies were comparable and appropriate to
determine statistical significance at the level of P<0.05 in all the studies.
The use of oxygen supplementation was determined to be beneficial in the time
preceding fetal umbilical clamping and is associated with higher maternal and fetal
oxygen levels (Chatmongkolchart & Prathep, 2013). Cooper et al. (2002) reported that
they did not use supplemental oxygen at any time before delivery of the neonate, whereas
Ngan Kee et al. (2008), Prakash et al. (2010) and Mercier et al. (2013) all administered
supplemental oxygen to participants. Mercier et al. (2013) reported an unknown amount
of oxygen administered via nasal cannula whereas both Ngan Kee et al. (2008) and
Prakash et al. (2010) both reported administration of oxygen via facemask of 6-8 liters.
Moslemi and Rasooli, (2015) and Copper et al. (2010) did not report on whether their
participants were given any oxygen supplementation. Since this use of oxygen
supplementation was demonstrated to be beneficial in other studies (Ngan Kee et
al.,2008; Mercier et al. (2013), Prakash et al.,2010), results of the Cooper et al. (2002)
study could have provided results of more fetal acidosis when compared to a similar
study with the use of supplemental oxygenation. The Cooper et al. (2002) study did find
that a lower pH was more frequent with ephedrine (10 out of 48) than with phenylephrine
(1 out of 48) or combination of both groups (1 out of 47) (overall P=0.0007) but puts into
question that if supplemental oxygen was given, would there be as many neonates with a
low pH in the ephedrine group?
The use of fluid prehydration before spinal administration has been demonstrated
to decrease the incidence of hypotension caused from spinal anesthesia (Riley, Cohen,
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Rubenstein & Flanagan, 1995). Cooper et al. (2002), Prakash et al. (2010), Mercier et al.
(2013) and Moslemi and Rasooli (2015) all administered some sort of prehydration to
their participants. Cooper et al. (2002), Prakash et al. (2010) and Mercier et al. (2013) all
administered a weight-based amount of fluid, while Moslemi and Rasooli (2015) only
administered a set 500ml boluses of prehydration to participants. Cooper et al (2010) did
not report on whether any prehydration was administered. Ngan Kee et al. (2008) did not
administer any hydration before spinal anesthesia but instead administered up to two
liters of Lactated Ringers solution as needed after spinal anesthesia was given. Although
the use of prehydration has been demonstrated to be helpful (Riley et al., 1995) it did not
seem to effect the variables in question. For example, in the Ngan Kee et al. (2008) no
prehydration was used and only 2 out of 102 neonates in the ephedrine group experienced
acidosis versus none in the phenylephrine group.
In 1941 the American Society of Anesthesiologists (ASA) published a booklet for
it’s members containing the first version of a ‘physical status’ classification for patients
about to undergo surgery (Fitz-Henry, 2011). The function of ASA classifying is to
quantify the amount of physiological reserve that a patient possesses at the time of the
assessment for a surgical procedure (Fitz-Henry, 2011). This may change before the
patient actually undergoes the procedure, either by optimization and improvement of their
physical state or because they deteriorate and have less reserve (Fitz-Henry). All of the
studies but one included patients that were healthy individuals of ASA classification I or
II with similar characteristics (none to mild systemic disturbances). Cooper et al. (2010)
examined high risk singleton pregnant subjects with a number of different comorbidities
such as prematurity, diabetes, labor problems, pregnancy induced hypertension and
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hypotension. High risk parturients have the potential for fetal complications such as fetal
acidosis and therefore cannot be compared to non-high risk parturients or healthy ASA
class I or II patients. For this reason, the Cooper et al. (2010) study results are not
comparable to the other five studies included in this systematic review.
The spinal solution used may effect the incidence of hypotension due to where the
site of action of the anesthetic tends to be (Miller & Pardo). Hyperbaric solutions are
heavier and tend to be lower within the intrathecal space and therefore may cause less
sympathectomy (Miller & Pardo). Since spinal anesthesia height is based on the
concentration and solution and not the volume of anesthesia, larger volumes give higher
blockade and therefore more sympathectomy leading to increased incidences of
hypotension (Miller & Pardo). Moslemi and Rasooli (2015) used 2.5 ml of Bupivacaine
0.5% (12.5mg) with 2.5 mcg of Sufentanil. Mercier et al. (2013) administered 11mg of
hyperbaric 0.5% Bupivacaine, 2.5 mcg Sufentanil and 0.1 mg morphine. Prakash et al.
(2010) administered 2ml 0.5% Hyperbaric Bupivacaine. Ngan Kee et al. (2008)
administered 2.0-2.2 ml of hyperbaric 0.5% bupivacaine (10-20 mg) and fentanyl 15
mcg. Cooper et al. (2010) reported no detail of solutions used but did report they were not
consistent. Cooper et al (2002) reportedly used four different techniques which were
chosen based on preference by whomever was administering the spinal anesthetic.
As described previously, local anesthetics can cause a sympathetic block, resulting in
parasympathetic override. This can produce hypotension due to a decrease in venous
return to the heart, a decrease in cardiac output and a decrease in systemic vascular
resistance (Miller & Pardo). The height of spinal anesthesia necessary for cesarean
section delivery has the increased incidence of hypotension due to this sympathectomy.
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Copper et al. (2010) reported the incidence of hypotension to be a systolic blood pressure
less than 90 mmHg and was found to be 6.1% in the no vasopressor group 17% in the
Ephedrine and 20% in the Phenylephrine group (P=0.005). Cooper et al. (2002) reported
that the lowest SABP recorded was higher in the P group (80% [73-88] of baseline) than
in the E group (73% [61-87] of baseline) (P=0.02) but the C group (77% [69-86] of
baseline) was not significantly different from the P (P=0.14) and E (P=0.25) groups. The
proportion of SABP readings below 80% of baseline was lower in the P group (0% [0-8])
(P+0.007) and in the C group (4% [0-10]) (P+0.04) than in the E group (8% [0-20]), but
there was no difference between the P and C groups (P=0.55). Ngan Kee et al. (2008)
reported an overall incidence of hypotension to be 74/102 (73%) of participants in the P
group and 74/102 (73%) of the E group had one or more episodes of hypotension
(P=0.52) and required one or more boluses of vasopressor. Prakash et al. (2010) reported
that the mean change in systolic pressure was comparable in the two groups with the
minimum being 100 in the E group and 93 in the P group (P=0.114) except at 8 minutes
where E group was lower (P=0.004). Mercier et al. (2013) reported the incidence of
hypotension was halved in the E+P (37%) group when compared with the E (75%) group
(P=0.02). SBP values after onset of spinal anesthesia were not significantly different
between the two groups. Moslemi, F., & Rasooli, S. (2015) reported SBP after anesthesia
every two and every five minutes were different (P>0.050) in the Ph and P groups.
Overall, the volume of spinal anesthetic was comparable across the studies as well as the
incidence of hypotension after the spinal administration and consequently does not
support identifying it as a contributing factor to the outcome of fetal acidosis.
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The main focus of this systematic review was to determine if ephedrine or
phenylephrine cause more or less fetal acidosis through the diversion of fetal blood flow,
potentially causing more harm than good when given to woman experiencing
hypotension (Nagelhout et al). . acidosis is determined through the umbilical cord blood
pH, specifically the artery. Fetal acidosis is defined as a pH less than 7.16 (some texts
state 7.20), with adverse neonatal outcomes occurring with a pH less than 7.0 (OmoAghoja, 2014). Cooper et al. (2010) and Cooper et al. (2002) both found there was no
true fetal acidosis but Cooper et al. (2002) did find that a lower pH was more frequent
with ephedrine (10 out of 48) than with phenylephrine (1 out of 48) or combination of
both groups (1 out of 47) (overall P=0.0007). The ephedrine group had a lower umbilical
artery pH than the phenylephrine group (P=0.002) or the combination group (P=0.009).
Ngan Kee, et al (2008) similarly found no statistical difference between the groups they
studied for fetal acidosis (p=0.70). However, in the ephedrine group there were two cases
(out of 102 cases) with umbilical artery pH less than 7.0 compared with no cases in the
phenylephrine group (p=0.50). Prakash et al. (2010) again found that no umbilical artery
pH was less than 7.20 but that umbilical artery and venous pH were significantly lower in
the ephedrine group than in the phenylephrine group (p=0.01 and P=0.002) but never
reached true acidosis.
Mercier et al. (2013), unlike the other studies, never used phenylephrine alone as
an intervention group; instead one group was given a combination of ephedrine and
phenylephrine and the other was given just ephedrine alone. They found that umbilical
venous and arterial pH values were significantly higher in the ephedrine and
phenylephrine combination group (average = 7.24) than in the ephedrine alone group
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(average = 7.19) (P=0.05). The incidence of arterial pH <7.20 was 31% in the ephedrine
and phenylephrine combination group and 63% in the ephedrine alone group (P=0.09).
Interestingly, Moslemi and Rasooli (2015) used three different intervention groups:
phenylephrine alone; ephedrine alone; and a placebo group that received no medication.
Umbilical artery blood gas analysis showed a significant difference in pH. Two neonates
out of 30 in the phenylephrine group, seven out of 27 in the ephedrine group and five out
of 26 in the placebo group had acidosis. Acidosis was significantly lower in
phenylephrine group (P=0.043).
Overall, out of all groups included in the different studies, the phenylephrine
group alone provided a higher pH than any other group alone or in combination but the
incidence of true fetal acidosis of a pH less than 7.16 (or 7.20) was extremely low and
thus insignificant. In all six studies, Apgar scores at one and five min were similar and
there were no statistically significant findings except for Moslemi and Rasooli (2015)
who found that there was a significant difference in the 5 min APGAR scores which was
better in the phenylephrine and ephedrine groups rather than the placebo group
(P=0.002). These findings suggest that the Apgar score does not depict neonatal outcome.
Incidentally, nausea and vomiting were frequently studied. Nausea and vomiting
is a side effect of hypotension but the correlation of nausea and vomiting specific to
ephedrine or phenylephrine had not been studied. Cooper et al. (2002) and Ngan Kee et
al. (2008) both examined nausea and vomiting in the intervention groups and both found
that there was more nausea and vomiting in the ephedrine groups. Cooper et al. (2002)
found that there was no change in the phenylephrine group from baseline nausea and
vomiting (P=0.30) but in the ephedrine and combination of phenylephrine and ephedrine
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group the nausea and vomiting increased from baseline (E= P<0.0001) (C = P=0.007).
There was no significant different between the ephedrine and combination groups
(P=0.09). In the E group vomiting (18 out of 48) was associated with decreased heart rate
and systolic blood pressure and increased ephedrine doses.
Next, the summary and conclusions will be presented.
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Summary and Conclusions
Hypotension during cesarean section delivery can have detrimental effects on
both the mother and the neonate (Lee et al., 2002). These effects include decreased
uteroplacental blood flow, impaired fetal oxygenation with asphyxial stress and fetal
acidosis (Lee et al.). Some vasoactive medications have been found to be detrimental to
the neonate and divert fetal blood flow, potentially causing more harm than good in
pregnant women (Nagelhout et al., 2013). Studies have shown that ephedrine can cause
fetal acidosis as a side effect and more so than phenylephrine; concerns about the adverse
effects of phenylephrine on uterine blood flow have also been reported. Ephedrine is a
mixed acting adrenergic receptor agonist that has both alpha and beta agonist properties.
Ephedrine’s predominant beta effect causes an increase in arterial pressure by increasing
cardiac output rather than by vasoconstriction. Phenylephrine is a pure alpha-adrenergic
agonist which increases the blood pressure through peripheral vasoconstriction
(Nagelhout et al.). A literature review of vasoactive drugs conducted on animals varied
in terms of the safety and efficacy of the two drugs. The results may not apply to the
human populations and may not be appropriate because of the species differences (Lee et
al., 2002).
This systematic review compared these two drugs and their efficacy on fetal and
maternal outcomes, specifically examining fetal acidosis through umbilical artery pH
testing. Outcomes assessed were maternal hypotension, spinal anesthetic used,
supplemental oxygenation, intravenous prehydration, ASA classification and Apgar
score. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) flowchart assisted in identifying appropriate research by providing a step-by-
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step approach with instructions related to those to be included as well as those to exclude
(Moher et al., 2009). Each included study was then illustrated in a table in order to
identify key variables being researched. The studies were then critically appraised using
the CASE worksheet (Foster & Shurtz, 2013). Finally, a cross study analysis was done to
examine key outcomes across the studied variables.
No direct conclusion can be drawn from any of the specific variables and their
effect on fetal acidosis mainly due to the differences in study design (oxygen
supplementation; ASA classification; IV fluid prehydration; hypotension incidence after
spinal anesthesia; spinal solution and technique; umbilical artery pH; Apgar scores;
nausea and vomiting during the case).
Related to oxygen supplementation, some of the studies reported the use of
oxygen supplementation whereas some did not report on the use while others reported no
use. Since the use of oxygen supplementation was demonstrated to be beneficial in three
studies, (Ngan Kee et al. [2008], Prakash et al. [2010] and Mercier et al. [2013]), studies
where no supplemental oxygen was used could have potentially resulted in more fetal
acidosis when compared to a similar study with the use of supplemental oxygenation.
High risk parturients have the potential for fetal complications such as fetal
acidosis and therefore cannot be compared to non-high risk parturients or healthy ASA
class I or II patients. For this reason, results of the Cooper et al. (2010) study, which
included all high risk parturients, are not comparable to the other five studies included in
this systematic review due to the high risk nature of the patients included.
Cooper et al. (2002), Prakash et al. (2010), Mercier et al. (2013) and Moslemi and
Rasooli (2015) all administered some sort of prehydration to their participants. Cooper et
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al. (2010) did not report on whether any prehydration was administered. Ngan Kee et al.
(2008) did not administer any hydration before spinal anesthesia but instead administered
up to two liters of Lactated Ringers solution as needed after spinal anesthesia was given.
The late use of IV hydration or none use could have contributed to hypotension
experienced during spinal anesthesia.
Overall, the volume of spinal anesthetic was comparable across the studies as well
as the incidence of hypotension after the spinal administration. Consequently, this does
not support identifying it as a contributing factor to the outcome of fetal acidosis.
In examining umbilical artery pH, Cooper et al. (2002), Cooper et al. (2010),
Ngan Kee, et al. (2008), Moslemi and Rasooli (2015) , and Prakash et al. (2010) found
that no umbilical artery pH < 7.20; however, umbilical artery and venous pH were
significantly lower in the ephedrine group than in the phenylephrine group but never
reached true acidosis. In contrast, Mercier et al. (2013) used a different study design and
found that umbilical venous and arterial pH values were significantly higher in the
ephedrine and phenylephrine combination group (average = 7.24) than in the ephedrine
alone group (average = 7.19) (P=0.05).
In all six studies, Apgar scores at one and five min were similar and there were no
statistically significant findings except for Moslemi and Rasooli (2015). These
researchers found that there was a significant difference in the 5 min APGAR scores,
which were better in the phenylephrine and ephedrine groups as compared to the placebo
group (P=0.002).
There was no difference between the two vasopressors in the incidence of true
fetal acidosis but it is clear that the use of phenylephrine was associated with a better fetal
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umbilical artery pH than in those women given ephedrine. Two of the studies included in
this systematic review included nausea and vomiting as a variable and found that there
was an increased incidence of nausea and vomiting with the administration of ephedrine.
Incidentally, Cooper et al. (2002) and Ngan Kee et al. (2008) both examined nausea and
vomiting in the intervention groups. Both authors found that there was more nausea and
vomiting in the ephedrine groups.
Limitations associated with this systematic review included that not all studies
reported on the use of oxygen supplementation in their participants. The dosages,
medications used and groups within the studies all varied across the studies, making
comparisons difficult. The sample sizes of some of the studies were small and the
participants included in five out of the six studies were all healthy women undergoing
elective c-section delivery, so extrapolation to situations where fetal compromise is
present or to emergency C-section delivery is challenging. The use of IV prehydration
may effect the incidence of hypotension and since some studies reported they did use it
and some did not, it is difficult to make comparisons across them.
In summary, this systematic review supports the cautioned use of ephedrine over
phenylephrine in the obstetric patient experiencing maternal hypotension during spinal
anesthesia for elective cesarean section delivery, despite limitations. The use of
phenylephrine was associated with better fetal pH status than ephedrine.
Recommendations and implications for advanced nursing practice will be
discussed in the next section.
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Recommendations and Implications for Advanced Nursing Practice
Systematic reviews provide a succinct review and critical analysis of existing
research studies regarding the same subject matter and can therefore offer key
information for evidence based practice. Certified Registered Nurse Anesthetists aim to
provide the safest care to all their patients and in doing so they rely on current evidencebased knowledge found through thorough research to guide their practice. The incidence
of hypotension after spinal anesthesia can not always be prevented but the vasopressor
used for treatment can be chosen using critical thinking and evidence-based knowledge
found through research.
Although the occurrence of true fetal acidosis could not be determined with the
use of either ephedrine or phenylephrine in the reviewed studies, the incidence of a
higher pH with phenylephrine should be taken in to consideration when choosing the best
vasopressor. Both ephedrine and phenylephrine groups had similar efficacy for
preventing or treating hypotension and there was no difference in clinical neonatal
outcome as measured by Apgar scores. Nevertheless, the objective of obstetric anesthesia
practice is to deliver the fetus in the best condition possible. The studies included
reported on the higher incidence of a lower normal pH with ephedrine. Caution should
also be taken with the use of ephedrine as the sole vasopressor of choice in obstetric
anesthesia and particularly in cases where there is an already increased risk of fetal
acidosis.
Continuing education on the indications, dosages and side effects of both
phenylephrine and ephedrine should be obtained prior to their use. No vasopressor alone
shows benefit over the other but caution should be used based on their side effects.
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Ephedrine results in lower pH values but true acidosis has not been seen and
phenylephrine’s primary alpha agonist properties promote it’s side effect of bradycardia.
Due to this, patients experiencing bradycardia should not be given phenylephrine as a
vasopressor because of the risk of worsening bradycardia. Based on the incidental finding
of nausea and vomiting associated with ephedrine use, caution should be taken with the
use of ephedrine in patients at high risk for nausea and vomiting or those already
experiencing such. Systematic reviews are intended to provide up to date information
regarding the latest, safest and most effective methods of anesthesia care. This
information can be used not only to improve the practice of existing practitioners, but
also become incorporated in the curriculum of institutions training future CRNAs.
No recommendations on policy change can be made when it comes to the use of
ephedrine and phenylephrine in choosing one over the other. Based on the conclusion of
this systematic review, both medications are acceptable for use in practice. Caution
should be taken with the use of ephedrine due to the outcome of lower normal pH than
phenylephrine, especially in patients with risk of fetal acidosis.
Further randomized controlled trials need to be conducted with larger sample
sizes and and including key variables aforementioned.. Through this research,
practitioners may be able to better gauge the use of ephedrine and phenylephrine in their
everyday practice. A separate study on the incidence of ephedrine-induced post-operative
nausea and vomiting should be completed to determine its role in the matter. These
studies would be essential in developing even safer and more effective protocols in
obstetric anesthesia.
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Appendix A-1
Data Collection Tool
Cooper, D. W., Sharma, S., Orakkan, P., & Gurung, S. (2010). Retrospective study of association between choice of vasopressor given
during spinal anesthesia for high-risk caesarean delivery and fetal pH. International Journal of Obstetric Anesthesia, 19(1), 44-49.
Method/Level
of evidence &
Major
Variables
Studied
Retrospective
observational
study and
chart review
over a 4-year
period from
2000-2003

Level III
(Retrospective
cohort study)

Maternal:
blood pressure
Fetal: 5 min
Apgar score,
umbilical

Sample/ Setting

Intervention

Data Analysis

Results

Limitations

Charts reviewed
were those in
the 4-year
period of 20002003, women
with high risk
pregnancies that
had a cesarean
section under
spinal
anesthesia for
singleton
delivery where
fetal umbilical
artery and
venous pH were
recorded and
these
participants
either received
ephedrine

Once women for the study
were identified, the authors
then reviewed the notes,
recording maternal and
fetal demographic and
operative data. Blood gas
values, taken from a
double clamped segment of
umbilical cord at delivery,
5 min Apgar scores
assessed by a midwife and
admission to the neonatal
unit were all recorded.
During the period of the
study, ephedrine was
routinely given as 6mg
boluses and phenylephrine
as 100 mcg boluses, at the
discretion of the
anesthetist. Phenylephrine
infusion was recommended

Primary outcome was
umbilical artery pH. 112
participants per group
would give the study an
80% chance of detecting a
0.03 difference in umbilical
artery pH, at P=0.05 based
on a standard deviation of
0.08 for umbilical artery pH
for non-elective C-section
under spinal anesthesia.
Secondary outcomes were
the incidence of fetal
acidosis (pH <7.20), low 5
min Apgar score (<7) and
admission to the neonatal
unit. Mann-Whitney and
Kruskal-Wallis tests were
used for direct comparison

The no vasopressor, ephedrine
and phenylephrine groups were
similar for demographic data but
there were differences for
diabetes (P=0.042), previous Csection (p=0.19), pregnancy
induced hypertension (P=0.003),
spinal local anesthetic dose
(P=0.006) and hypotension
(P=0.005). The median total dose
of ephedrine given before
delivery was 12mg; the median
total dose of phenylephrine in
given before delivery was 200
mcg. The authors were unable to
find accurate records of the dose
of vasopressor given by infusion.
13% of the ephedrine group were
given a second line vasopressor
(median total dose 200 mcg)
compared with 5% of the

Low doses of
ephedrine used,
cofounding variables
were not examined.
Prematurity and labor
may have contributed
to the lack of
difference between the
vasopressor groups in
this high risk study by
reducing hypotension
and therefore,
vasopressor
requirements. Urgent
nature of the surgery
for many of the high
risk cases may also
have reduced the
difference between the
groups by reducing the
spinal delivery interval.
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artery and
venous pH
values

boluses,
ephedrine
infusion,
phenylephrine
bolus or
phenylephrine
infusion for low
blood pressures

No vasopressor
n=115
Ephedrine total
n=122
(Ephedrine
bolus n=110
Ephedrine
infusion n= 12)
Phenylephrine
total n=148
(Phenylephrine
bolus n=51
Phenylephrine
infusion n=97)

only to be given according
to a standard protocol,
which had been developed
for a prospective study
completed in 2001 at our
hospital. Phenylephrine
was started at 33 mcg/min
immediately following
spinal injection and then
titrated aiming to keep
systolic blood pressure
(SBP) at baseline. The
infusion rate was doubled
or halved as required. The
Max infusion rate was 67
mcg/min. If there was
hypotension despite the
prophylactic infusion, 100
mcg boluses of
phenylephrine were given.
There were no guidelines
for ephedrine infusion.
Criteria for admission to
the neonatal unit were
gestation <34 weeks,
weight <1800g or poor
condition.

of the groups and
subgroups.
Forward stepwise multiple
regression analysis was used
to find which independent
variables were associated
with umbilical artery pH.
The potential explanatory
variables entered into the
multiple regression analysis
were choice of vasopressor,
method of administration,
time period, maternal age,
maternal height, maternal
weight, gestational age, fetal
weight, previous C-section,
spinal dose, spinal delivery
interval, hypotension, direct
involvement of a consultant
obstetrician. Data were
analyzed using SPSS
version 12. P = <0.05 was
regarded as statistically
significant

phenylephrine group (all
ephedrine boluses, median total
dose 9 mg) (P=0.014). There was
no difference in umbilical artery
pH between the three groups on
direct comparison (P=0.21).
Following forward stepwise
multiple regression analysis, the
only variable that was associated
with altered pH was nonreassuring fetal heart rate trace
(P=0.71). On direct comparison
there was no difference in the
incidence of umbilical artery pH
<7.20 (P=0.21), or 5 min Apgar
score <7 (0.089), between the
groups, but there was a
difference in the incidence of
admissions to the neonatal unit
(0.040), 37% of patients in the
phenylephrine group were
admitted, 23% in ephedrine
group and 33% in no vasopressor
group. The authors observations
for umbilical artery pH differ
from those in low risk
participants which show a higher
pH with phenylephrine.

There was no accurate
record of maternal
oxygen administration
which can affect
umbilical venous PO2.
The ephedrine and
phenylephrine groups
were not matched for
potential confounding
variables such as time
period of operation,
method of vasopressor
administration, labor,
and bupivacaine dose.
This could have biased
the univariate analysis.
Arterial pressure was
documented by hand so
there may have been a
degree of selective
recording or rounding
up of readings.
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Appendix A-2
Data Collection Tool
Cooper, D. W., Carpenter, M., Mowbray, P., Desira, W. R., Ryall, D. M., & Kokri, M. S. (2002). Fetal and maternal effects of
phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. The Journal of the American Society of Anesthesiologists,
97(6), 1582-1590.
Method/lev
el of
evidence &
Major
variables
studied
Randomized
/Double
blind study
Level II
evidence
Maternal:
blood
pressure and
heart rate,
Nausea and
vomiting
scores.
Fetal: Apgar
score,
umbilical
artery pH
and venous
pH

Sample/
Setting
Inclusion:
ASA I and II
participants
scheduled
for elective
C-section
under spinal
anesthesia.
Singleton
pregnancies,
with no fetal
abnormalitie
s and no
history of
preeclampsi
a or diabetes
mellitus.
Exclusion:
ASA >III,
non elective
C-sections,
C-sections
requiring

Intervention

Data Analysis

Results

Limitations

Before entering the anesthesia room, the
participants had 3 blood pressure and heart
rate readings recorded with an automated
oscillometer at 3 min intervals while sitting
in bed. The lowest of the 3 readings was
recorded as the baseline values. The highest
nausea and vomiting score was recorded for
30 min before the spinal (0= none, 1= nausea
with no vomiting, 2= vomiting). participants
were randomly allocated by envelope
selection to one of 3 vasopressor solutions to
maintain maternal systolic arterial pressure.
The participants, anesthetists, nurses and
midwives involved were all blinded to the
patient grouping. The P group received
phenylephrine 100mcg/ml. the E group
received ephedrine 3mg/ml and the C group
received a combination of phenylephrine
50mcg/ml combined with ephedrine
1.5mg/ml. These concentrations were based
on unpublished pilot work performed at the
hospital where the study took place to find
solutions of similar potency. A third party not
involved with the study opened an envelop

The study was
designed to
have an 80%
chance of
detecting a 15%
incidence of
fetal acidosis
(umbilical
artery pH
<7.20) in the
ephedrine
group (E
Group) and an
80% chance of
detecting a
difference of
0.03 in the
mean umbilical
artery pH at
P=0.05. The
Kruskal-Wallis
test was used to
compare the
three groups. If

48 (n=48) participants in the phenylephrine
group (P group), 50 (n=50) in the ephedrine
group (E Group) and 49 (n=49) in
combination of phenylephrine and
ephedrine solution group (C group) were
studied. The 3 groups were comparable for
age, height, weight, gestation, breech
presentation, previous c-section, delivery
and birth weight. The groups were well
matched for the spinal anesthetics given (P=
0.99), the investigators collecting data
(P=0.77) and for the uterine incision to
delivery interval (P=0.10).
Overall the mean systolic arterial blood
pressure (SABP) from spinal until delivery
was similar for all three groups as was the
SABP over time for the 3 groups. There was
a small but statistically significant
difference between 20 and 25 min postspinal when the MAP was lower in the
phenylephrine group than in the epidural
and combination groups. The incidence of
hypotension (SABP <80%) was similar for
the 3 groups. However, there was a small

Code had to
be broken in
two of the
ephedrine
cases due to
hypotension
not
responding
to
ephedrine.
All
participants
were healthy
women
undergoing
elective Csection
delivery so
extrapolatio
n to
situations
where fetal
compromise
is present or
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general
anesthesia,
multiple
fetuses, fetal
abnormalitie
s or history
of
preeclampsi
a or
diabetes.

containing the code for the patient group and
gave the investigator the relevant unlabeled
syringe. The solution was further diluted to to
a total of 40ml. One of 4 spinal anesthetics
techniques was used based on provider
preference. To avoid bias, randomization was
stratified by using separate set of
randomization envelopes for each of the
standard spinal anesthetics techniques.
Technique 1: 2.5ml of spinal hyperbaric
0.5% bupivacaine with 20mcg of fentanyl
given in sitting position. Technique 2: 2ml of
spinal levobupivacaine 0.5% with 20 mcg
fentanyl given in the sitting position before
an epidural catheter was inserted. Technique
3: 2ml of spinal levobupivacaine 0.5% with
20 mcg, given in the left lateral position
before an epidural catheter was inserted.
Technique 4: 2.5ml of spinal levobupivacaine
0.5% with 10 mcg of fentanyl, given in the
left lateral position before an epidural
catheter was inserted. The level of the spinal
was measured 10 min post-spinal and at skin
incision. Target block height was T5. An
epidural top-up, using 0.5% levobupivacaine
was only used pre-delivery if neural blockade
was not sufficiently high or dense with spinal
anesthesia alone. Immediately before spinal
anesthesia a preload of 10ml/kg of Hartmann
solution as rapidly infused. Immediately
following spinal injection, the infusion of IV
vasopressor solution was started according to
protocol. The patient was then positioned
supine with a left lateral tilt. Systolic arterial
pressure and heart rate were measured every
minute using the same oscillometer as the
baseline. The rate of the solution was

a difference
was found with
the KruskalWallis test,
pairs of groups
were then
compared using
the MannWhitney U test.
The Wilcoxon
signed-rank test
and spearman
rank test were
also used to
analyze data.
The Wilcoxon
signed-rank test
was used to
compare data
within a group.
P<0.05 was
considered
significant.

but statistically significant differences
between the 3 groups for the lowest SABP
recorded and for the proportion of SABP
readings below 80% of baseline (P=0.02).
The lowest SABP recorded was higher in
the P group (80% [73-88] of baseline) than
in the E group (73% [61-87] of baseline)
(P=0.02) but the C group (77% [69-86] of
baseline) was not significantly different
from the P (P=0.14) and E (P=0.25) groups.
The proportion of SABP readings below
80% of baseline was lower in the P group
(0% [0-8]) (P+0.007) and in the C group
(4% [0-10]) (P+0.04) than in the E group
(8% [0-20]), but there was no difference
between the P and C groups (P=0.55). from
5 min onward the HR was higher in the E
group than in the P and C groups. Overall
the mean HR in the C group was lower than
in the E group (P<0.0001) and higher than
in the phenylephrine group (P=0.008). The
highest HR recorded differed between the
groups (P<0.0001): it was higher in the E
group (137% [124-156] of baseline) than in
the P group (115% [108-128] of baseline)
(P<0.0001) and the C group (122% [109140] of baseline) (P+0.004), but there was
no difference between the P and C groups
(P=0.051). Fetal acidosis was less frequent
in the P group (1 of 48) and less frequent in
the C group (1 of 47) than in the E group
(10 of 48) (overall P=0.0007). There was no
difference in the incidence of fetal acidosis
between the P and C groups (P=0.99). 1 and
5 min APGAR scores were good in all 3
groups and no infant required intubation or
admission to the special care baby unit.

to
emergency
C-section
delivery
may not be
valid. All
participants
were fluid
preloaded
which could
also add to
the high
baseline
blood
pressures.
The doses of
ephedrine
and
phenylephri
ne used
were based
on an
unpublished
pilot work
performed at
the same
hospital.
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doubled or halved if the systolic arterial
blood pressure (BP) fell below or above 0.75
times the baseline. Phenylephrine was started
at 33mcg/min; ephedrine was started at
1mg/min or half the dose rate for each for the
combination solution. The max infusion rate
was 40ml/hr. and min rate was 1.3ml/hr. If
more than 40ml/hr. was required 1 or 2ml
boluses of trial solution could be given. If the
systolic arterial pressure was above 1.25
times the baseline the infusion was stopped
and restarted at half the rate when the systolic
arterial pressure was below 1.25 times the
baseline again. The max nausea and vomiting
score was recorded between spinal and
delivery. At delivery one of the investigators
obtained umbilical artery and vein blood
samples from a segment of the umbilical cord
double clamped before the baby’s first
breath. No supplemental O2 was given to the
mother prior to delivery. APGAR scores
recorded at 1 and 5 minutes by a midwife and
the need for tracheal intubation, ventilation or
admission to the special care baby unit were
recorded.

Blood gas values were similar for the P and
C groups. The E group had a lower
umbilical artery pH than the P group
(P=0.002) or the C group (P=0.009), and a
lower umbilical vein pH than the P group
(P=0.04) or the C group (P=0.003). There
was no difference in the umbilical vein
PCO2 between the groups but the E group
had a higher umbilical artery PCO2 than the
P group (P=0.002). Baseline N/V
(nausea/vomiting) scores were similar for
all 3 groups. There was no change in the P
group from baseline N/V scores (P=0.30)
but in the E and C group the N/V scores
increased from baseline (E= P<0.0001) (C =
P=0.007). The N/V scores were lower in the
P group than in the E group (P<0.0001) or
C group (P<0.0001) but there was no
significant different between the E and C
groups (P=0.09). In the E group vomiting
(n=18) was associated with decreased HR
and SABP and increased ephedrine doses.
There was no difference in the block height
at 10 min or at skin incision for the E group
participants who vomited, compared with
the E group participants without N/V
(P=0.57 and P=0.36).
The incidence of fetal acidosis and vomiting
at cesarean delivery under spinal anesthesia
was reduced by giving phenylephrine alone
or in combo with ephedrine compared with
giving ephedrine alone.

55

Appendix A-3
Data Collection Tool
Ngan Kee, W. D., Khaw, K. S., Lau, T. K., Ng, F. F., Chui, K., & Ng, K. L. (2008). Randomized double-blinded comparison of
phenylephrine vs. ephedrine for maintaining blood pressure during spinal anesthesia for the non-elective Caesarean section.
Anesthesia, 63(12), 1319-1326.
Method/level
of evidence &
Major
variables
studied
Randomized/D
ouble blind
study using
computergenerated
codes
contained in
opaque seal
and
sequentially
numbered
envelopes.
Level II
evidence
Maternal:
blood pressure
and heart rate
and Nausea
and vomiting
Fetal: Apgar
score and
umbilical
artery blood

Sample/
Setting
204 (n=204)
Inclusion:
ASA I and II
women with
singleton
pregnancies
scheduled for
non-elective
C-section for
which spinal
anesthesia
was decided
upon for
clinical
reasons at any
point in time.
Exclusion:
participants
with preexisting or
pregnancy
induced
hypertension,
cardiovascula

Intervention

Data Analysis

Results

Limitations

participants were premedicated with
0.3M Na citrate 30 ml on arrival to the
OR. Standard monitoring included
noninvasive BP measurement, ECG and
pulse Oximetry. Fetal HR (heart rate)
was monitored by external
cardiotocography until surgical prep. No
IV prehydration was given. Spinal
anesthesia was induced with the patient
in the right lateral position. After skin
infiltration with lidocaine, a 25-gauge
pencil point needle was inserted at what
was estimated to be L3-4 or L4-5
vertebral interspace and 2.0-2.2 ml of
hyperbaric 0.5% bupivacaine (10-20
mg) and fentanyl 15 mcg was injected
intrathecally. The patient was then
immediately turned to supine with a left
lateral tilt and a rapid IV co-hydration
with up to 2 liters of lactated ringer’s
solution, oxygen of 6-8 L/min was
administered by clear facemask until
delivery. BP (blood pressure) was
measured at 1 min intervals beginning at
1 minute after spinal injection.

85 participants
(n=85) per group
would be required
to have a 90%
power at the 0.05
significance level
to detect a
difference
between groups.
Primary analysis
was performed on
an intention to
treat basis and a
secondary
analysis was
performed on a
per protocol basis
to compare only
protocolcompliant
participants who
actually required
treatment for
hypotension with
a vasopressor.

Data collection was completed over a
2-year period. Overall 74/102 (73%) of
participants in the P group and 74/102
(73%) of the E group had one or more
episodes of hypotension and required
one or more boluses of vasopressor
(p=0.52). The number of episodes of
hypotension and the total volume of IV
fluid given in each group was similar.
The min recorded HR was lower in the
P group vs the E group but there was
no difference in max recorded HR or
min and max SBP recorded. The
number of doses of vasopressor
required was similar between groups.
More participants had N/V in the E
group than the P group (13/102
(12.7%) vs 4/102 (3.9%), P=0.02).
There was no difference between
groups in the primary outcome, UA pH
(p=0.70). In the E group 2 cases had a
UA pH <7.0 compared with no cases in
the P group (P=0.50). the UA PO2 was
lower in the P group vs the E group
(Median difference 0.23 (95% CI of

Insufficient
amount of UA
blood was
obtained in 1
patient in the P
group and 2
participants in
the E group.
Insufficient UV
blood was
obtained for
analysis in 2
participants in
the E group. 8
UA sample and
1 UV sample
was below the
min reportable
limit range.
After the study
commenced a
study was
published by
Saravanan et al.
reporting that
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gases and
venous blood
gases

r or
cerebrovascul
ar disease,
multiple
gestation,
known fetal
abnormality
or any
medical
contraindicati
ons to spinal
anesthesia
such as
thrombocytop
enia or
coagulopathy

Hypotension as defined as SBP (systolic
blood pressure) <100 mmHg.
participants were randomized to receive
an IV bolus of either phenylephrine 100
mcg (group P) or ephedrine 10 mg
(group E) immediately after each
episode of hypotension. The doses of the
drugs were chosen based on clinical
experience. The upper sensory level of
the spinal anesthesia was tested at 5 min
after the spinal injection. Skin incision,
uterine incision and delivery were all
recorded. Vasopressor protocol was
continued until the time of uterine
incision. The total dose of vasopressor
given up to time of uterine decision, the
total volume of IV fluid given and any
incidence of nausea or vomiting and the
number of episodes of hypotension was
recorded. Bradycardia was defined as
HR <50 bpm. The attending pediatrician
assessed APGAR scores at 1 and 5 min
after delivery. We recorded the number
of neonates admitted to the special care
baby unit and neonatal intensive care
unit and the duration of stays. Umbilical
arterial (UA) and umbilical venous (UV)
blood samples from double-clamped
segments of umbilical cord were
obtained.

Univariate
intergroup
comparisons were
made using the
unpaired student’s
t-test or the
Mann-Whitney Utest as
appropriate.
Nominal data
were compared
using the ChiSquare test or
Fisher’s exact
test. Analyses
were made using
SPSS version
10.1.4 and
confidence
interval Analysis
2.0.0. Values of
p<0.05 were
considered
statistically
significant.

difference 0.20-0.45) p=0.032) and UV
PO2 was lower in the P group vs the E
group (Median difference 0.39 (95% CI
of difference 0.08-0.70) P=0.012).
However, there was no difference
between groups in UA or UV oxygen
content. There was no difference
between groups in the clinical outcome
of the neonates. One neonate in the E
group had an APGAR score <7 at 1
min and 5 min and one neonate in the P
group had an APGAR score <7 at 1
min; all other APGAR score were >7.
17 neonates (17%) in the P group and
21 (21%) neonates in the E group were
admitted to the special care baby unit
(P=0.045). There was no difference in
the duration of stay between groups. In
the ephedrine group UA lactate was
higher and UV lactate was higher, UA
pO2 and UV PO2 were lower in the P
group although O2 content was similar.
More participants had nausea or
vomiting in the E group but there was
no other difference in clinical outcome.
Both Phenylephrine and Ephedrine are
suitable vasopressors for use in nonelective C-sections.

the potency
ratio of
phenylephrine:
ephedrine was
approximately
80:1
(Phenylephrine
100 mcg =
ephedrine 8mg)
when the drugs
were given by
infusion
therefore the
doses used in
this study were
not equipotent.
There was a
relatively small
amount of
vasopressors
used in this
study and that
may explain the
findings to be
not lower in the
E group as
predicted in
multiple
previous
studies.
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Appendix A-4
Data Collection Tool
Prakash, S., Pramanik, V., Chellani, H., Salhan, S., & Gogia, A. R. (2010). Maternal and neonatal effects of bolus administration of
ephedrine and phenylephrine during spinal anesthesia for caesarean delivery: a randomized study. International Journal of Obstetric
Anesthesia, 19(1), 24-30.
Method/level
of evidence
&
Major
variables
studied
Randomized/
Double blind
study with
computer
generated
number
allocation
Level II
evidence
Maternal:
blood
pressure and
heart rate
Fetal: Apgar
score and
umbilical
artery pH and
venous pH

Intervention

Data Analysis

Results

Limitations

All women received ranitidine and metoclopramide
for antacid prophylaxis. Standard monitoring with
on-invasive arterial pressure, electrocardiography
and pulse oximetry was established.
Women rested undisturbed in the supine position
with left uterine displacement for 5 min following
which baseline blood pressure and heart rate were
calculated as the mean of three successive readings
measured 1 min apart. Each patient also received a
10ml/kg IV infusion of Lactated Ringers solution
over 15-20 min before spinal anesthesia.
With participants in the left lateral position, 2ml
0.5% Hyperbaric Bupivacaine was injected
intrathecally at L3-4 via a 25 gauge Quincke needle.
participants were then immediately turned supine
and positioned with left uterine displacement. Heart
rate and blood pressure were recorded at 1 min
intervals from the time of induction of spinal
anesthesia until delivery. Oxygen 6L/min via face
mask was delivered until delivery. Sensory block to
the T5 dermatome was considered adequate for
surgery.

A total of 23
women per
group would
have a 90%
power at the 5%
significance
level to detect a
difference in
umbilical
arterial pH of
0.03 between
groups. To
allow for
potential dropouts a total of
30 participants
per group with a
SBP <80% of
baseline were
recruited

The two groups were
comparable in age, weight,
height, baseline hemodynamic
data and dermatomal sensory
levels. There were no
significant differences in the
mean induction to delivery or
uterine to delivery intervals
between the two groups.
Although not significant,
induction to delivery times
varied, hemodynamic changes
were compared up to 20 min
after induction of spinal
anesthesia, by which time 59
out of 60 women had
delivered. The mean change
in systolic pressure was
comparable in the two groups
with the minimum being 100
in the E group and 93 in the P
group (P=0.114) except at 8
minutes where E group was
lower (P=0.004). The fall in

Sample size
was small. All
participants
were healthy
women
undergoing
elective Csection
delivery so
extrapolation
to situations
where fetal
compromise is
present or to
emergency Csection
delivery may
not be valid.
There was a
high baseline
blood pressure
than could of
been due to the
setting where

Sample/
Setting
A total of 60
women who
developed
hypotension
participated.
n=30 in the
ephedrine
group, n=30 in
the
Phenylephrine
group
Inclusion:
ASA 1 women
with singleton
pregnancies
scheduled for
elective
caesarean
delivery under
spinal
anesthesia
were recruited.

Descripting
statistics were
calculated for

58

Exclusion:
Women with
pre-existing or
pregnancy
induced
hypertension,
diabetes
mellitus,
known
cardiovascular
or
cerebrovascula
r disease, fetal
abnormality,
or
contraindicatio
n to spinal
anesthesia.

Women were randomly assigned to received one of
two vasopressor solutions whenever systolic pressure
decreased to 80% of baseline or less.
participants were divided into 2 groups: P group
(phenylephrine) and E group (ephedrine). Group E
received 1ml bolus of ephedrine 6mg/ml, group P
received a 1 ml bolus of phenylephrine 100 mcg/ml.
Additional boluses were administered if the systolic
pressure remained at or below 80% of baseline.
Atropine was administered in 0.3mg increments
whenever bradycardia was associated with systolic
pressure less than baseline or if the heart rate was
<45 bpm The incidence of maternal tachycardia
(>100 bpm) and reactive hypertension (>20% of
baseline) were recorded after the administration of
either ephedrine in group E or phenylephrine in
group P. The number of vasopressor doses required,
total doses of vasopressor administered, time of first
administration of vasopressor, requirement for
atropine and its relation to vasopressor
administration were noted. The time of induction of
spinal anesthesia, uterine incision and delivery were
recorded. After delivery oxytocin 5 units was given
by slow IV injection followed by a 10-unit infusion.
The incidence of nausea and vomiting was recorded.
Arterial and venous blood samples were obtained
from a double clamped segment of the umbilical
cord and analyzed within 10 minutes. Apgar scores
at 1, 5 and 10 minutes were determined by the
attending pediatrician who was unaware of group
assignment. Time and onset of sustained rhythmic
respiration was noted.

continuous
variables as
mean and
standard
deviation and
for categorical
variables as
frequency of
distribution and
percentage. To
assess trend
within
variables, twoway analysis of
variance was
used. P < 0.05
was regarded as
statistically
significant.
SPSS 14.0 for
Windows
statistical
software was
used for
analysis.

heart rate below mean baseline
in group P was significantly
greater than in group E (20±
10 vs 6± 0.6, P<0.001). In all
cases, bradycardia developed
following phenylephrine
administration. Birth weight
and Apgar scores at 1
(p=0.739), 5 (p=0.128) and 10
min (p=0.611) were
comparable in the two groups.
No neonate had an Apgar
score <7 at any time. Time to
onset of rhythmic respiration
was <90s in all cases. No
neonate required tracheal
intubation or admission to the
neonatal intensive care unit.
No umbilical artery pH was
less than 7.20. Umbilical
artery and venous pH were
significantly lower in group E
than in group P (p=0.01 and
P=0.002)
Results showed the 100 mcg
bolus doses of phenylephrine
are as effective as 6 mg bolus
doses of ephedrine in the
treatment of hypotension
following spinal anesthesia in
term parturients undergoing csection delivery. Neonates of
women treated with
phenylephrine had higher
umbilical cord pH though true
fetal acidosis was not seen in
any neonate.

the baseline
was taken that
being the OR
which is a high
stress
environment.
All
participants
were fluid
preloaded
which could
also add to the
high baseline
blood
pressures. The
doses of
ephedrine and
phenylephrine
used were
based on
clinical
experience of
the authors
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Appendix A-5
Data Collection Tool
Mercier, F. J., Augè, M., Hoffmann, C., Fischer, C., & Le Gouez, A. (2013). Maternal hypotension during spinal anesthesia for
caesarean delivery. Minerva Anestesiol, 79(1), 62-73.
Method/
level of
evidence
&
Major
variable
s studied
Randomi
zed
doubleblind
study
using a
random
table
with
stratificat
ion to
allocate
participa
nts to
each
group
Level II
evidence
Maternal
: blood
pressure

Sample/
Setting

42 parturients
(n=42)
scheduled for
Caesarean
section (Csection)
delivery
using spinal
anesthesia.
Inclusion: age
18-years or
older, weight
90Kg or less,
height 152cm
or greater,
ASA I or II,
and term
singleton
pregnancy.
Exclusion:
parturients
with

Intervention

Data Analysis

Results

Limitations

Participants were fasted overnight and were given
30 ml of sodium citrate. Oxygen was administered
to all participants via nasal cannula. Standard
monitors included electrocardiogram, noninvasive
BP device and pulse oximetry. After an
intravenous (IV) preload of 15ml/kg of Lactated
Ringer’s Solution (LR) was given, spinal
anesthesia was performed at the L2-L3 or L3-L4
interspace with the patient sitting, using a 9 cm 25
gauge whitacre spinal needle. 11mg of hyperbaric
0.5% Bupivacaine, 2.5 mcg Sufentanil and 0.1 mg
morphine was injected through the spinal needle.
Participants were then immediately placed in the
recumbent position with left uterine displacement.
A prophylactic vasopressor IV infusion was started
at the end of spinal injection. participants received
either 2mg/min ephedrine plus 10 mcg/min
phenylephrine (E+P group) or 2mg/min ephedrine
alone (E group). Study solutions were prepared by
an anesthesiologist or a nurse anesthetist not
involved in the participant’s care and according to
the group indicated in a numbered sealed
envelope. One of the investigators was present

Data was expressed
as mean ± SD
unless stated
otherwise. Groups
were compared for
single parametric,
ordinal and
nominal variables
suing unpaired
student t test, the
Mann-Whitney U
test, and Fisher
exact test,
respectively.
Hemodynamic
values over time
were compared
using analysis of
variance for
repeated measures,
followed by
Dunnett tests. A
forward stepwise

Participants characteristics,
gestational age, neonatal weight,
upper sensory level of anesthesia at
20 min and time intervals from
spinal anesthesia to incision, from
spinal anesthesia to delivery and
from uterine incision to delivery
were comparable between the two
groups. Baseline SBP and maternal
HR were also comparable between
the groups.
The incidence of hypotension was
halved in the E+P (37%) group
when compared with the E (75%)
group (P=0.02). SBP values after
onset of spinal anesthesia were not
significantly different between the
two groups. Minimal SBP values
before delivery were lower in the E
group but the difference was no
statistically significant (P=0.08).
Hypotensive episodes were brief
and of similar cumulative duration

Phenylephrine
alone group
studied would
have allowed
for a broader
knowledge
base.
Hypotension
was found to
be very
frequent in
this study and
more
prophylaxis
should be
used.
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Fetal:
Umbilica
l cord
blood pH
and
Apgar
scores

pregnancyinduced
hypertension,
cardiac
disease,
diabetes, or
fetal
complications
, and those in
labor

during the study period to confirm comparability
of routine procedures. The primary outcome
variable was the incidence of hypotension, defined
as a systolic blood pressure (SBP) <100 mmHg
and less than 80% of baseline before delivery.
Baseline SBP and maternal heart rate (HR) were
determined by the average of 3 measurements
obtained before preloading with LR. After spinal
injection SBP and maternal HR were measured
every minute for 10 min and every 2 min there
after until delivery. A predefined algorithm was
used to adjust the syringe rate according to SBP as
follows:
-maintain rate if SBP within 90-105% of baseline
-Rate halved if SBP 105-120% of baseline
-Stop if SBP >120% of baseline
-Rate doubled if SBP 80-90% of baseline
-SBP <100 mmHg and <80% of baseline treated
with 6mg ephedrine bolus doses repeated as
needed.
For each subject, a min and max SBP and HR
were recorded before delivery. A back up plan
designed to treat several critical situations allowed
anesthesiologist to administer epinephrine,
addition phenylephrine or atropine as needed. The
upper level of sensory changes was determined
using an alcohol swab 20 min after spinal
injection. Additional data collection included time
intervals from spinal anesthesia to incision, from
spinal anesthesia to delivery, and from uterine
incision to delivery, the dose of vasopressor
infused until delivery, venous and arterial
umbilical cord pH values, neonatal Apgar scores
and neonatal weight.

regression analysis
was performed to
determine the
association
between venous or
arterial umbilical
blood pH with the
following five
variables: duration
of hypotension,
total ephedrine
dose, time interval
from spinal
anesthesia to skin
incision, time from
spinal anesthesia to
delivery, and time
from uterine
incision to
delivery. P <0.05
was considered
significant. Sample
size calculations
indicated that
including 37
participants in the
study would result
in an 80% power to
detect a decrease
from 75 to 37.5%
in the incidence of
hypotension at a
significance level
of 0.05

in both groups. Max SBP and Min
heart rate were also comparable.
Max heart rate before delivery was
15 bpm higher in the E group than
in the E + P group (P=0.02).
Maternal heart rate after onset of
spinal anesthesia was significantly
increased in the E group from 3 to 6
min after spinal anesthesia (P<0.05)
and remained unchanged in the E+P
group. Significantly more ephedrine
was infused and supplementation
given in the E group. Umbilical
venous and arterial pH values were
significantly higher in the E+P
group (7.24) than in the E group
(7.19) (P=0.05).
The incidence of arterial pH <7.20
was 31% higher in the E+P group
and 63% in the E group (P=0.09).
However, Apgar scores at 1 and 5
min were similar in both groups
(p=0.7) and were never less than 7.
Low venous and arterial pH values
were associated only with the E
group assignment and spinal
anesthesia to delivery times longer
than 33 min.
Compared with ephedrine alone
ephedrine plus phenylephrine
infusions decreased the incidence of
hypotension by approx. 50%,
abolished maternal tachycardia, and
improved venous and arterial pH.
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Appendix A-6
Data Collection Tool
Moslemi, F., & Rasooli, S. (2015). Comparison of prophylactic infusion of phenylephrine with ephedrine for prevention of
hypotension in elective cesarean section under spinal anesthesia: a randomized clinical trial. Iranian Journal of Medical Sciences,
40(1), 19.
Method/level of
evidence &
Major variables
studied
Randomized/Double
blind study using a
table of random
numbers and a
computer generated
randomization list.

Sample/
Setting
90 women
(n=90) for
elective csection under
spinal
anesthesia were
recruited.

Level II evidence
Maternal: blood
pressure and heart
rate
Fetal: Apgar score
and umbilical artery
blood gases

Inclusion:
healthy
pregnant
women with
gestational age
of 36 weeks or
higher and nonemergency csection
Exclusion: <36
weeks of
gestation,
emergency csection, high
risk
pregnancies
(multiple

Intervention

Data
Analysis

Results

Limitations

participants were assigned to 3 different
groups: phenylephrine (group Ph),
ephedrine (group E) and placebo (group P).
Upon arrival to the OR all participants were
monitored for basal vital signs (HR, SBP,
DBP, and SaO2). Prior to spinal anesthesia
all participants received a 500 ml
crystalloid bolus. Infusion of study drugs
were: group Ph received 450 mcg of
phenylephrine in 250 ml, group E received
45 mg of ephedrine in 250 ml and group P
received an infusion of only 250 ml normal
saline. All solutions were label with
numerical codes. The nurses that infused
the solutions and monitored the vital signs
were blinded to the solutions. The
participants then received spinal anesthesia
by an anesthesiologist in the sitting position
from L4/5 or L3/4 inter-vertebral spaces
with 2.5 ml of Bupivacaine 0.5% (12.5mg)
and 2.5 mcg of Sufentanil. Immediately
after spinal placement all participants were
positioned in the supine position with left
uterine displacement. BP (blood pressure)
was controlled every 2 minutes until

Data was
analyzed
using a oneway
ANOVA for
quantitative
variables and
Fishers exact
probability
tests and chisquare for
qualitative
variables and
associations.
Multiple
comparisons
were tested
by post-hoc
with Turkey
technique.
Normal
distributions
of data were
evaluated by
Kolmogorov-

In total 83 participants (n=83) were
studied: 30 women in group Ph
(n=30), 27 in group E (n=27) and 26
in group P (n-26). There was no
significant difference in
demographic data. Indications for csection were: repeated c-section
(n=53), other indications (n=25) and
patient preference (n=4).
There was no significant difference
between the 3 groups in basal SBP
(systolic blood pressure), how ever
SBP after anesthesia every 2 and
every 5 minutes were different
(P>0.050) in the Ph and P groups.
There was no significant difference
between groups for HR (heart rate)
except for the 1st 3 measurements of
every 5 minutes (P=0.006). 38
participants in all groups had severe
hypotension and needed additional
vasopressor therapy: group Ph=10,
group E-15, group P=20. There was
a significant difference between
group Ph and groups E and P.

Sample size
was small.
All
participants
were healthy
women
undergoing
elective Csection
delivery so
extrapolation
to situations
where fetal
compromise
is present or
to emergency
C-section
delivery may
not be valid.
All
participants
were fluid
preloaded
which could
also add to
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gestations,
intrauterine
growth
retardation,
preeclampsia,
maternal
cardiovascular
or pulmonary
diseases), any
contraindication
of spinal
anesthesia
(patient refusal,
coagulopathy,
hemorrhage or
hypovolemic
shock) and
unexpected
events during
surgery such a
hemorrhage or
sensory block
level higher or
lower than T4T5 after spinal
anesthesia

delivery and then every 5 minutes
throughout anesthesia as were HR (heart
rate) and SaO2 (oxygen saturation).
Sensory block was monitored to obtain a
T4-T5 level of anesthesia. After delivery
and clamping of the umbilical cord, 1ml of
blood was drawn from the umbilical artery
for neonatal blood gas analysis. Any
decrease in BP of about 20% from baseline
was treated with 50-100 mcg phenylephrine
in pH group or 5-10 mg ephedrine in E and
P groups. This was repeated as required.
These drugs were prepared in numerical
labeled syringes and were given to the
nurses blindly. They were instructed to
administer 1ml of that drug solution if
hypotension was greater than 20% of
baseline (1ml of phenylephrine was 50mcg
and 1ml of ephedrine was 5mg). HR and
rhythm were monitored with ECG and any
change from normal (PVC, tachycardia,
bradycardia) were recorded and treated as
needed. The incidence and degree of
hypotension, number of vasopressor
therapy and the total dose of injected
vasopressor in each group were measured
and recorded. 1min and 5 min APGAR
scores were recorded as well as umbilical
artery blood gas analysis.

Smirnov
normality
test. Analysis
was
performed
using SPSS
16.0
program.
Statistical
results were
considered
significant
when
P<0.05.

Additional doses required for the
treatment of hypotension was higher
in groups E (65.2%, n=15) and P
(80%, n=20) than in group Ph
(28.57%, n=10). Overall bradycardia
was more significant in the
phenylephrine group and ephedrine
group than the placebo group
(P<0.001). There was no significant
difference in 1 min APGAR scores
between the groups. There was a
significant difference in the 5 min
APGAR scores which was better
with group Ph and E rather than
group P (P=0.002). UA (umbilical
artery) blood gas analysis showed a
significant difference in pH and
PCO2 between Ph and P groups. 2
neonates in the Ph group, 7 in the E
group and 5 in the P group had
acidosis. Acidosis was significantly
lower in phenylephrine group
(P=0.043)
Overall results showed that women
who underwent spinal anesthesia for
elective c-section, SBPs and
neonatal
UA pH were best maintained with a
prophylactic infusion of
phenylephrine compared with those
who did not receive it and even
better than those who received
prophylactic ephedrine.

the high
baseline
blood
pressures.
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Appendix B-1
CASE worksheet
Cooper, D. W., Sharma, S., Orakkan, P., & Gurung, S. (2010). Retrospective study of
association between choice of vasopressor given during spinal anesthesia for high-risk
caesarean delivery and fetal pH. International Journal of Obstetric Anesthesia, 19(1), 4449.

Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation
Summary Topic
1. Is the summary specific in scope and
Yes- The aim of the study is clearly stated as well
application?
as the patients that the summary applies to are
well described
Summary Methods

2. Is the authorship of the summary
transparent?
3. Are the reviewer(s)/editor(s) of the
summary transparent?
4. Are the research methods transparent
and comprehensive?
5.

6.
7.
8.
9.

10.

No - The individual authors are listed but their
credentialing is not listed. Affiliation is listed.
No- It is not clearly stated that the summary has
been edited and reviewed
Yes- The inclusion and exclusion criteria is clearly
stated. A protocol for the study was Cleary stated
and followed.
Is the evidence grading system
Yes- Retrospective observational/chart review
transparent and translatable?
study was performed. Protocol used in reviewing
charts was clearly stated.
Summary Content
Are the recommendations clear?
Yes- recommendations are clearly stated and
multiple options for treatment are provided
Are the recommendations appropriately
Yes- recommendations are appropriately cited
cited?
Are the recommendations current?
No- The recommendations are from 2010 so not
within 2 years therefore not updated or current
Is the summary unbiased?
Unable to appropriately assess if there is a
conflict of interest between the
recommendations of the summary and the
sponsor for any author
Summary Application
Can this summary be applied to your
Yes- This evidence and setting applies to my
patient(s)?
population and can be translated to any patient
within the same population and setting.
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Appendix B-2
CASE worksheet
Cooper, D. W., Carpenter, M., Mowbray, P., Desira, W. R., Ryall, D. M., & Kokri, M. S.
(2002). Fetal and maternal effects of phenylephrine and ephedrine during spinal
anesthesia for cesarean delivery. The Journal of the American Society of
Anesthesiologists, 97(6), 1582-1590.

Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation
Summary Topic
1. Is the summary specific in scope and
Yes- The aim of the study is clearly stated as well
application?
as the patients that the summary applies to are
well described
Summary Methods

2. Is the authorship of the summary
transparent?
3. Are the reviewer(s)/editor(s) of the
summary transparent?
4. Are the research methods transparent
and comprehensive?
5.

6.
7.
8.
9.

10.

Yes - The individual authors are listed with their
credentialing as well as affiliations.
No- It is not clearly stated that the summary has
been edited and reviewed
Yes- The inclusion and exclusion criteria is clearly
stated. A protocol for the study was Cleary stated
and followed.
Is the evidence grading system
Yes- Randomized double-blinded study – stated
transparent and translatable?
that randomization was performed by randomly
allocating patients by envelop selection to one of
three groups all participants and investigators
were blinded to the group, unlabeled syringes
were used. A third party not involved in the study
opened the envelop and handed the appropriate
medication to the investigator.
Summary Content
Are the recommendations clear?
Yes- recommendations are clearly stated and
multiple options for treatment are provided
Are the recommendations appropriately
Yes- recommendations are appropriately cited
cited?
Are the recommendations current?
No- The recommendations are from 2002 so not
within 2 years therefore not updated or current
Is the summary unbiased?
Unable to appropriately assess if there is a
conflict of interest between the
recommendations of the summary and the
sponsor for any author
Summary Application
Can this summary be applied to your
Yes- This evidence and setting applies to my
patient(s)?
population and can be translated to any patient
within the same population and setting.
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Appendix B-3
CASE worksheet
Ngan Kee, W. D., Khaw, K. S., Lau, T. K., Ng, F. F., Chui, K., & Ng, K. L. (2008).
Randomized double-blinded comparison of phenylephrine vs. ephedrine for maintaining
blood pressure during spinal anesthesia for the non-elective Caesarean section.
Anesthesia, 63(12), 1319-1326.

Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation
Summary Topic
1. Is the summary specific in scope and
Yes- The aim of the study is clearly stated as well
application?
as the patients that the summary applies to are
well described
Summary Methods

2. Is the authorship of the summary
transparent?

3.
4.

5.

6.
7.
8.
9.

10.

Not completely- Although the individual authors
are listed their credentialing is not listed but their
affiliations are. The process to become in author
is also not described.
Are the reviewer(s)/editor(s) of the
No- It is not clearly stated that the summary has
summary transparent?
been edited and reviewed
Are the research methods transparent
Yes- The inclusion and exclusion criteria is clearly
and comprehensive?
stated. A protocol for the study was Cleary stated
and followed.
Is the evidence grading system
Yes- Randomized double-blinded study – stated
transparent and translatable?
that randomization was performed using
computer generated codes contained in opaque,
sealed and sequentially numbered envelops as
well as medications prepared in identical syringes
but someone not involved in the study
Summary Content
Are the recommendations clear?
Yes- recommendations are clearly stated and
multiple options for treatment are provided
Are the recommendations appropriately
Yes- recommendations are appropriately cited
cited?
Are the recommendations current?
No- The recommendations are from 2008 so not
within 2 years therefore not updated or current
Is the summary unbiased?
Unable to appropriately assess if there is a
conflict of interest between the
recommendations of the summary and the
sponsor for any author
Summary Application
Can this summary be applied to your
Yes- This evidence and setting applies to my
patient(s)?
population and can be translated to any patient
within the same population and setting.
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Appendix B-4
CASE worksheet
Prakash, S., Pramanik, V., Chellani, H., Salhan, S., & Gogia, A. R. (2010). Maternal and
neonatal effects of bolus administration of ephedrine and phenylephrine during spinal
anesthesia for caesarean delivery: a randomized study. International Journal of Obstetric
Anesthesia, 19(1), 24-30.

Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation
Summary Topic
1. Is the summary specific in scope and
Yes- The aim of the study is clearly stated as well
application?
as the patients that the summary applies to are
well described
Summary Methods

2. Is the authorship of the summary
transparent?
3.
4.

5.

6.
7.
8.
9.

10.

Not completely - The individual authors are listed
but their credentialing is not listed. Affiliation is
listed.
Are the reviewer(s)/editor(s) of the
No- It is not clearly stated that the summary has
summary transparent?
been edited and reviewed
Are the research methods transparent
Yes- The inclusion and exclusion criteria is clearly
and comprehensive?
stated. A protocol for the study was Cleary stated
and followed.
Is the evidence grading system
Yes- Randomized double-blinded study – stated
transparent and translatable?
that randomization was performed by computer
generated number allocation, identical syringes
prepared by someone not involved with data
collection.
Summary Content
Are the recommendations clear?
Yes- recommendations are clearly stated and
multiple options for treatment are provided
Are the recommendations appropriately
Yes- recommendations are appropriately cited
cited?
Are the recommendations current?
No- The recommendations are from 2009 so not
within 2 years therefore not updated or current
Is the summary unbiased?
Unable to appropriately assess if there is a
conflict of interest between the
recommendations of the summary and the
sponsor for any author
Summary Application
Can this summary be applied to your
Yes- This evidence and setting applies to my
patient(s)?
population and can be translated to any patient
within the same population and setting.
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Appendix B-5
CASE worksheet
Mercier, F. J., Augè, M., Hoffmann, C., Fischer, C., & Le Gouez, A. (2013). Maternal
hypotension during spinal anesthesia for caesarean delivery. Minerva Anestesiol, 79(1),
62-73.

Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation
Summary Topic
1. Is the summary specific in scope and
Yes- The aim of the study is clearly stated as well
application?
as the patients that the summary applies to are
well described
Summary Methods

2. Is the authorship of the summary
transparent?
3. Are the reviewer(s)/editor(s) of the
summary transparent?
4. Are the research methods transparent
and comprehensive?
5.

6.
7.
8.
9.

10.

Yes - The individual authors are listed with their
credentialing and affiliations.
No- It is not clearly stated that the summary has
been edited and reviewed
Yes- The inclusion and exclusion criteria is clearly
stated. A protocol for the study was Cleary stated
and followed.
Is the evidence grading system
Yes- Randomized double-blinded study – stated
transparent and translatable?
that randomization was performed by using
numbered, sealed, opaque envelopes ensuring
both the patient and investigators were blinded
to group assignment and study solutions were
prepared by those not involved in the patients
care and according to the group indicated by the
envelope. There was an investigator present
during the study period to confirm comparability
and routine procedures.
Summary Content
Are the recommendations clear?
Yes- recommendations are clearly stated and
multiple options for treatment are provided
Are the recommendations appropriately
Yes- recommendations are appropriately cited
cited?
Are the recommendations current?
No- The recommendations are from 2001 so not
within 2 years therefore not updated or current
Is the summary unbiased?
Unable to appropriately assess if there is a
conflict of interest between the
recommendations of the summary and the
sponsor for any author
Summary Application
Can this summary be applied to your
Yes- This evidence and setting applies to my
patient(s)?
population and can be translated to any patient
within the same population and setting.
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Appendix B-6
CASE worksheet
Moslemi, F., & Rasooli, S. (2015). Comparison of prophylactic infusion of phenylephrine
with ephedrine for prevention of hypotension in elective cesarean section under spinal
anesthesia: a randomized clinical trial. Iranian Journal of Medical Sciences, 40(1), 19.

Critical Appraisal for Summaries of Evidence (CASE) Worksheet
*Numbers in evaluation correspond with those assigned to articles in data extrapolation chart*

Questions

Evaluation
Summary Topic
1. Is the summary specific in scope and
Yes- The aim of the study is clearly stated as well
application?
as the patients that the summary applies to are
well described
Summary Methods

2. Is the authorship of the summary
transparent?
3. Are the reviewer(s)/editor(s) of the
summary transparent?
4. Are the research methods transparent
and comprehensive?
5.

6.
7.
8.
9.

10.

Yes - The individual authors are listed with their
credentialing as well as affiliations.
No- It is not clearly stated that the summary has
been edited and reviewed
Yes- The inclusion and exclusion criteria is clearly
stated. A protocol for the study was Cleary stated
and followed.
Is the evidence grading system
Yes- Randomized clinical trial – stated that
transparent and translatable?
randomization was performed using a table of
random numbers and computer generated
randomization list
Summary Content
Are the recommendations clear?
Yes- recommendations are clearly stated and
multiple options for treatment are provided
Are the recommendations appropriately
Yes- recommendations are appropriately cited
cited?
Are the recommendations current?
Yes- The recommendations are from 2015, they
are current.
Is the summary unbiased?
Unable to appropriately assess if there is a
conflict of interest between the
recommendations of the summary and the
sponsor for any author
Summary Application
Can this summary be applied to your
Yes- This evidence and setting applies to my
patient(s)?
population and can be translated to any patient
within the same population and setting.
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Appendix C
Descriptive Data Synthesis
Oxygen
supplementation
Used

Intravenous
Fluid
Prehydration

Cooper
et al.,
2010

Not reported

Not reported

Cooper
et al.,
2002

No supplemental
O2 was given to
the mother prior
to delivery.

Immediately
before spinal
anesthesia a
preload of
10ml/kg of
Hartmann
solution as
rapidly
infused.

Study

ASA
Classification/
patient
characteristics
High risk
singleton
pregnant
patients

Hypotension
incidence
after spinal
Anesthesia
SBP <90
mmHg: No
vasopressor
group 6.1%,
group E 17%
and group P
20%
(P=0.005)

Spinal
Solution
and
Technique
No detail but
reported to
be non
consistent

ASA I and II
participants
scheduled for
elective Csection under
spinal
anesthesia.
Singleton
pregnancies,
with no fetal
abnormalities

The lowest
SABP
recorded was
higher in the
P group (80%
[73-88] of
baseline) than
in the E
group (73%
[61-87] of
baseline)

4 different
spinal
anesthetic
solutions/tec
hniques
were used
based on
provider
presence
To avoid
bias,

Umbilical
Artery pH

Apgar
scores

On direct
comparison
there was
no
difference
in the
incidence of
umbilical
artery pH
<7.20
(P=0.21),

On direct
comparis
on there
was no
difference
in 5 min
Apgar
score <7
(0.089),

Fetal
acidosis
was less
frequent in
the P group
(1 of 48)
and less
frequent in
the C group
(1 of 47)
than in the

1 and 5
min
APGAR
scores
were
good in
all 3
groups

N/V during
case

Other
important
findings
Following
forward
stepwise
multiple
regression
analysis,
the only
variable
that was
associated
with
altered pH
was nonreassuring
fetal heart
rate trace
(P=0.71).

Baseline N/V
(nausea/vomi
ting) scores
were similar
for all 3
groups. There
was no
change in the
P group from
baseline N/V
scores

70

and no history
of preeclampsia
or diabetes
mellitus.

(P=0.02) but
the C group
(77% [69-86]
of baseline)
was not
significantly
different from
the P
(P=0.14) and
E (P=0.25)
groups. The
proportion of
SABP
readings
below 80% of
baseline was
lower in the P
group (0% [08]) (P+0.007)
and in the C
group (4% [010]) (P+0.04)
than in the E
group (8% [020]), but
there was no
difference
between the P
and C groups
(P=0.55).

randomizatio
n was
stratified by
using
separate set
of
randomizatio
n envelopes
for each of
the standard
spinal
anesthetics
techniques.

E group (10
of 48)
(overall
P=0.0007).
There was
no
difference
in the
incidence of
fetal
acidosis
between the
P and C
groups
(P=0.99).
Blood gas
values were
similar for
the P and C
groups. The
E group had
a lower
umbilical
artery pH
than the P
group
(P=0.002)
or the C
group
(P=0.009),
and a lower
umbilical
vein pH
than the P
group
(P=0.04) or

(P=0.30) but
in the E and
C group the
N/V scores
increased
from baseline
(E=
P<0.0001) (C
= P=0.007).
The N/V
scores were
lower in the P
group than in
the E group
(P<0.0001)
or C group
(P<0.0001)
but there was
no significant
different
between the
E and C
groups
(P=0.09). In
the E group
vomiting
(n=18) was
associated
with
decreased HR
and SABP
and increased
ephedrine
doses.
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Ngan
Kee, et
al.,
2008

Prakash
et al.,
2010

After spinal
administration and
patient positioned
supine oxygen of
6-8 L/min was
administered by
clear facemask
until delivery

No IV
prehydration
was given

Oxygen 6L/min
via face mask was
delivered after

Each patient
received a
10ml/kg IV

After spinal
administration
and patient
positioned
supine a rapid
IV cohydration with
up to 2 liters of
lactated
ringer’s
solution was
given.

ASA I and II
women with
singleton
pregnancies
scheduled for
non-elective Csection for
which spinal
anesthesia was
decided upon
for clinical
reasons at any
point in time.

Overall
74/102 (73%)
of
participants
in the P group
and 74/102
(73%) of the
E group had
one or more
episodes of
hypotension
(P=0.52) and
required one
or more
boluses of
vasopressor.

ASA 1 women
with singleton
pregnancies

The mean
change in
systolic

Spinal
anesthesia
was induced
with the
patient in the
right lateral
position.
After skin
infiltration
with
lidocaine, a
25-gauge
pencil point
needle was
inserted at
what was
estimated to
be L3-4 or
L4-5
vertebral
interspace
and 2.0-2.2
ml of
hyperbaric
0.5%
bupivacaine
(10-20 mg)
and fentanyl
15 mcg was
injected
intrathecally.
The
With
participants
in the left

the C group
(P=0.003).
There was
no
difference
between
groups in
the primary
outcome,
UA pH
(P=0.70). In
the E group
2 cases had
a UA pH
<7.0
compared
with no
cases in the
P group
(P=0.50).

No
umbilical
artery pH

One
neonate
in the E
group had
an
APGAR
score <7
at 1 min
and 5 min
and one
neonate
in the P
group had
an
APGAR
score <7
at 1 min;
all other
APGAR
score
were >7.

Apgar
scores at
1

More
participants
had N/V in
the E group
than the P
group
(13/102
(12.7%) vs
4/102 (3.9%),
P=0.02).
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Mercier
et al.,
2013

spinal
administration and
positioning until
delivery

infusion of
Lactated
Ringers
solution over
15-20 min
before spinal
anesthesia.

scheduled for
elective
caesarean
delivery under
spinal
anesthesia

pressure was
comparable
in the two
groups with
the minimum
being 100 in
the E group
and 93 in the
P group
(P=0.114)
except at 8
minutes
where E
group was
lower
(P=0.004).

lateral
position, 2ml
0.5%
Hyperbaric
Bupivacaine
was injected
intrathecally
at L3-4 via a
25 gauge
Quincke
needle.

was less
than 7.20.
Umbilical
artery and
venous pH
were
significantly
lower in
group E
than in
group P
(p=0.01 and
P=0.002)
but never
reached true
acidosis

Oxygen was
administered to all
participants via
nasal cannula of
unknown amount.

intravenous
(IV) preload of
15ml/kg of
Lactated
Ringer’s
Solution (LR)
was given

Age 18-years or
older, weight
90Kg or less,
height 152cm or
greater, ASA I
or II, and term
singleton
pregnancy.

The incidence
of
hypotension
was halved in
the E+P
(37%) group
when
compared
with the E
(75%) group
(P=0.02).
SBP values
after onset of
spinal
anesthesia
were not
significantly
different

Spinal
anesthesia
was
performed at
the L2-L3 or
L3-L4
interspace
with the
patient
sitting, using
a 9 cm 25
gauge
whitacre
spinal
needle.
11mg of
hyperbaric
0.5%
Bupivacaine,

Umbilical
venous and
arterial pH
values were
significantly
higher in
the E+P
group (7.24)
than in the
E group
(7.19)
(P=0.05).
The
incidence of
arterial pH
<7.20 was
31% higher
in the E+P

(p=0.739)
,5
(p=0.128)
and 10
min
(p=0.611)
were
comparab
le in the
two
groups.
No
neonate
had an
Apgar
score <7
at any
time.
Apgar
scores at
1 and 5
min were
similar in
both
groups
(p=0.7)
and were
never less
than 7.

Low
venous and
arterial pH
values
were
associated
only with
the E group
assignment
and spinal
anesthesia
to delivery
times
longer than
33 min.
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between the
two groups.

Moslem
i, F., &
Rasooli,
S.
(2015).

Not reported

Prior to spinal
anesthesia all
participants
received a 500
ml crystalloid
bolus.

healthy
pregnant
women with
gestational age
of 36 weeks or
higher and nonemergency csection

SBP after
anesthesia
every 2 and
every 5
minutes were
different
(P>0.050) in
the Ph and P
groups.

2.5 mcg
Sufentanil
and 0.1 mg
morphine
was injected
through the
spinal
needle.
participants
then
received
spinal
anesthesia
by an
anesthesiolo
gist in the
sitting
position
from L4/5 or
L3/4 intervertebral
spaces with
2.5 ml of
Bupivacaine
0.5%
(12.5mg)
and 2.5 mcg
of
Sufentanil.

group and
63% in the
E group
(P=0.09).

UA
(umbilical
artery)
blood gas
analysis
showed a
significant
difference
in pH
between the
Ph and P
groups. 2
neonates in
the Ph
group, 7 in
the E group
and 5 in the
P group had
acidosis.
Acidosis
was
significantly
lower in
phenylephri
ne group
(P=0.043)

There
was no
significan
t
difference
in the 1
min
APGAR
scores
between
all of the
groups.
There
was a
significan
t
difference
in the 5
min
APGAR
scores
was
shown to
be better
with
group Ph
and E
than with

74

group P
(P=0.002)

